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Abstract (English)
Adaptive immune responses require the exchange of information between T cells and Antigen
Presenting cells (APCs). T cell receptors (TCRs) search and bind to processed antigen peptide
bound to major histocompatibility complexes (pMHC) on the APC surface. During this process
the surface molecules of the two cells are re-organized into a characteristic spatial pattern, known
as Immunological Synapse (IS). The contact interface is segregated in three distinct regions, the
central, peripheral and distal supramolecular activation clusters (c, p and dSMAC), occupied by
different molecules. The formation of a stable IS leads to key events during the immune response,
including T cell activation, fate decision and effector function such as killing of infected cells.
An agent-based model based on TCR-pMHC and LFA-1-ICAM-1 interactions was developed
in order to investigate the mechanisms leading to the characteristic IS formation. Size-based
segregation (SBS) for different sized complexes and coupling of molecules to the centripetal flow
of F-actin are the considered mechanisms, and are discussed for additional molecules, such as the
costimulatory CD28 and CD2, as well as the CD45 phosphatase, all important for TCR signaling.
SBS and centripetal flow resulted in the accumulation of TCR-pMHC in the center of the IS and
the emergence of a peripheral LFA-1-ICAM-1 gradient which acted as an exclusion mechanism of
molecules and complexes from the IS. The model predicted a mechanism of CD28/CD2 movement,
according to which CD28/CD2 complexes passively follow TCR-pMHC movement. The character-
istic annular CD28-CD80 pattern around the cSMAC only emerged with a particular CD28-actin
coupling strength that induced a centripetal motion, whereas the CD2 corolla pattern formation
required a CD2-CD2 self attraction but no interaction with the actin network.
The centripetal flow of TCR-pMHC complexes acted as a mechanism of TCR cooperativity,
while active modulation of the association rate by F-actin foci showed that the global affinity of
TCR toward pMHC molecules can be positively modulated.
The efforts to understand the mechanisms of IS formation can help in developing therapeutic
targets aiming the formation of stable synapses, in cases like cancer and autoimmune diseases
where impaired and unstable synapses and therefore defects on T cell activation are observed.
Keywords: Immune synapse formation, Agent-based modeling, Molecular localization, Pat-
tern formation, TCR cooperativity, F-actin foci

Zusammenfassung (Deutsch)
Adaptive Immunreaktionen erfordern den Informationsaustausch zwischen T-Zellen und Antigen
Presenting-Zellen (APCs). T-Zell-Rezeptoren (TCR) suchen und binden an prozessierte Antigen-
peptide, die auf pMHC auf der APC-Oberfla¨che gebunden sind. Wa¨hrend dieses Vorgangs werden
die Oberfla¨chenmoleku¨le der beiden Zellen zu einem charakteristischen ra¨umlichen Muster reor-
ganisiert, das als Immunologische Synapse (IS) bekannt ist. Die IS ist in drei verschiedene Bereiche
unterteilt, die zentralen, peripheren und distalen supramolekularen Aktivierungscluster (c, p und
dSMAC), die von verschiedenen Moleku¨len besetzt sind. Die Bildung einer stabilen IS fu¨hrt zu
Schlu¨sselereignissen wa¨hrend der Immunreaktion, wie der T-Zell-Aktivierung oder Differenzierung
zu Subtypen wie der zytotoxischen T-Zelle.
Ein Agenten-basiertes Modell wurde entwickelt, das TCR-pMHC und LFA-1-ICAM-1 Wechsel-
wirkungen beschreibt, um die Mechanismen der Bildung von IS zu untersuchen. Die gro¨ßenbasierte
Segregation (SBS) fu¨r unterschiedliche große Komplexe und die Ankopplung von Moleku¨len an den
zentripetalen Fluss von F-Aktin wurden implementiert und fu¨r die TCR-Signalvermittlung wichti-
gen kostimulatorischen Moleku¨le CD28 und CD2 sowie die CD45-Phosphatase diskutiert.
SBS und F-Aktin Zentripetalfluss fu¨hrten zur Ansammlung von TCR-pMHC im Zentrum der IS
und zur Entstehung eines peripheren LFA-1-ICAM-1-Gradienten, der als Ausschlussmechanismus
von Moleku¨len und Komplexen aus der IS fungierte. Das Modell sagte einen neuen Mechanismus
vorher, nach dem CD28/CD2 den TCR-pMHC-Komplexen passiv in Microclustern folgen.
Das ringfo¨rmige CD28-CD80-Muster um den cSMAC erfordert deren zentrale Bewegung mit
einer bestimmten CD28-Aktin-Kopplungssta¨rke. Die CD2 corolla-Bildung erfordert eine CD2-
CD2-Selbstanziehung aber keine Kopplung an F-Aktin.
Der Zentripetalfluss von TCR-pMHC-Komplexen wirkte als Mechanismus der TCR Koopera-
tivita¨t. Die aktive Modulation der Assoziationsrate durch F-Aktin-Foci ermo¨glicht eine Modulation
der globale Affinita¨t von TCR und pMHC-Moleku¨len.
Das verbesserte Versta¨ndnis der Mechanismen der IS-Bildung kann helfen, Therapien zu en-
twickeln, die auf die Bildung stabiler Synapsen abzielen, beispielsweise bei Krebs und Autoim-
munerkrankungen, bei denen beeintra¨chtigte und instabile Synapsen und daher Defekte bei der
T-Zellaktivierung beobachtet werden.




for always being next to me
during tough and good moments
mentally supporting me whenever required
and enjoying the successes together.

Acknowledgements
The time is over. That’s it. Many memories and many more stories to be told. These stories
of course exist thanks to certain people, who made my PhD life and my life in Braunschweig in
general a lot easier.
Philippe Paul August Robert, not only the best supervisor one can ask for but also a very good
friend. Always there to help at work when needed, and always there when it comes to fun. Always
willing to go for a beer, where we could discuss everything...form science and economy to politics
and our lives and dreams. But we were not alone, Ananya Rastogi was also there. We started the
same day at the lab, and we had to do all the lovely paperwork together! We had the same fears
and this created a very good friendship. We teased her a lot for her diet choices, but it was all
coming from our hearts!
Michael Meyer-Hermann. I have to admit I was lucky. You don’t find a boss like him every day.
Lively discussions, amazing ideas but most importantly a person you feel familiar with. Working
with him gave me motivation to become better every day and deliver the best I can. I would also
like to thank the rest of the lab members for creating a nice atmosphere.
I would also like to thank my collaborators from the University of Oxford and especially Michael
Dustin. Working and discussing with him helped me understand the nature and importance of the
synapse and also improve the modeling with his intellectual input.
I can not leave my family out of this...can I? Of course not! My mother, Eleni, and my father,
Menelaos for supporting me all the years of my studies and believing in me. My brother Nikos,
whose words back in winter of 2007, boosted my ego and motivated me to pursue becoming a
Mathematician. He is still one of my biggest fans you know! Of course, I could never forget my
late grandfather, Anastasios (yes we have the same name), who talked about me full of pride,
trying to explain to my grandmother, Iordana, what the hell I am doing in Germany!
Last but not least, the person who motivates me every single day, the person who was always
by my side, supporting me, creating a lovely environment and calming me down whenever I was
over the edge, my other half and partner, Calypso!




TCR T cell receptor
pMHC Antigen peptide bound to major histocompatibility complex
LFA-1 Lymphocyte function-associated antigen 1
ICAM-1 Intercellular adhesion molecule 1
CD28 Cluster of differentiation 28
CD80 Cluster of differentiation 80
CD2 Cluster of differentiation 2
CD58 Cluster of differentiation 58
CD45 Cluster of differentiation 45
APC Antigen Presenting Cell
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1.1 The immune system
Billions of bacteria, viruses, fungi and parasites are constantly attacking our bodies in order to
make it their home. The high energy concentration of our bodies is the perfect environment for
these microorganisms in order to thrive. Thankfully humans have developed a multifaceted and
complex defence army, the so called immune system. The immune systems consists of a complex
network of cells, tissue and organs that work together in order to keep us healthy. Organs and
tissue include the skin, mucous and membranes, the bone marrow, the thymus, lymph nodes and
lymphatic vessels, tonsils and the spleen (Figure 1.1). These organs utilize, assist and promote the
presence of different cell types, such as granulocytes, macrophages (MΦs), neutrophils, dendritic
cells (DCs), natural killer (NK) cells, as well as B and T lymphocytes, in order to properly repel
the attacks.
The foreign substances entering our bodies have developed evasion mechanisms to hide from the
immune system. Luckily, the immune system has also “evolved” and developed ways to recognise
and clear such foreign microorganisms. All jawed vertebrates, including humans, have developed
a very diverse and sophisticated two-layered defence system, the innate or non-specific immunity
and the adaptive or acquired or specific immunity [1–3]. The first line of defence is by blocking the
entrance of these microorganisms to the body with the help of skin and mucous. If this barrier is
breached and the microorganisms manage to enter the body, innate immune responses are initiated.
This is a non-specific and immediate defence against all the foreign organisms entering the body [4].
One can simply think of the innate immune system as a detection mechanism. If the pathogens
manage to break through the innate immune barrier too, adaptive immune responses take over,
this time in a specific manner [3, 5].
Randomly generated pattern recognition receptors (PRRs) identify microorganisms entering
the body and rapidly initiate the innate immune response. Phagocytes, such us macrophages
and neutrophils, are recruited to the area of foreign invasion and begin to kill or inactivate the
foreign objects. In this way the spread of the microorganisms throughout other parts of the body
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is stopped or at least delayed [4, 6, 7]. The innate immune response though is short lived, but
essential to “buy time” for the second, “smarter” way of defence, the adaptive immune response,
to take over. The adaptive immune response involves two types of immunity, the humoral and the
cell-mediated immunity [8–18]. Humoral immune response is mediated by B lymphocytes, while
cell-mediated immunity comes in the form of T lymphocytes. The cells taking part in the defence
system are depicted in Figure 1.2.
B cells can recognise 3D structures, such as proteins, lipids and native antigens. Their B cell
receptor (BCR) can even detect soluble antigen. When encountering foreign antigen (Ag), B cells
endocytose it, process it and present parts of it on their surfaces. The Ag is bound to major
histocompatibility complexes of class II in the form of peptide-Ag, annotated as pMHC. The B
cells in this case act as antigen presenting cells, APCs. B cells then migrate to the lymph nodes and
interact with T helper cells (TH) [19]. This interactions will lead to TH activation which in turn
release some special molecules called cytokines that induce rapid B cell proliferation [20–23]. The
new B cell clones will become either plasma or memory cells. The plasma cells produce antibodies
that on one hand can bind to foreign cells in order to inhibit their functions and on the other
hand can attract phagocytes and killer cells in order to eliminate the invaders [24–26]. Memory
cells remain inactivated and the next time they encounter the same antigen, they produce new
plasma cells, starting in this way a faster immune response [27–31]. Other kinds of APCs include
dendritic cells and macrophages [32–37]. DCs are also considered mediators of communication
between innate and adaptive immune responses [38].
The cell-mediated immune response requires the recognition of Ag by the T cells, which will lead
to further action. As mentioned before, Ag is processed by APCs, such as B cells, dendritic cells,
macrophages and in general all innate immune cells, and presented on their surfaces through a non
foreign Ag, bound to MHC. T cells can only recognise Ag by binding their T cell receptor (TCR)
to MHC complexes and different T cell types recognize the presented Ag in different ways [39].
When TCR binds to Ag presented through class I MHC, we refer to killer or cytotoxic T
cells [40], whereas when binding to class II MHC, we refer to helper and regulatory T cells. In
order to get activated, killer T cells need additional signals from a co-receptor of TCR known as
CD8, and therefore these cells are also called CD8+ T cells. Similarly, helper and regulatory T
cells need the assistance of the CD4 co-receptor and are known as CD4+ T cells [4]. Other types
of T cells such as natural killer T (NKT) cells, that share the properties of natural killer (NK) and
T cells are not considered as classical T cells [41, 42].
Once cytotoxic T cells get activated, they travel through the body in search of the same Ag
that they initially recognized. When a cell with this Ag is found, they release toxins in order to kill
it. The killing is performed either by release of perforin which disrupts the infected cell membrane
or by release of granulysin that induces the apoptosis of the infected cell [43–46].
Helper T cells on the other hand instead of killing, are the commanders of the body’s defence,
by instructing other cells, such as cytotoxic and natural killer (NK) cells [47, 48], to perform this
job. Once helper T cells get activated due to the Ag recognition, cytokines are released which
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drive the other cells to either kill or in the case of B cell to produce antibodies [4, 49–52].
One role of regulatory T cells (Tregs) is, as their name suggests, to regulate the activation
state of other cells, in order to avoid excessive and uncontrolled killing [53–56]. These are Foxp3
expressing T cells. Interestingly, it is suggested that CD4+Foxp3+ Tregs accumulate in skeletal
muscle shortly after acute injury and assist in muscle repair [57,58].
Natural killer (NK) cells are considered innate immune cells, which can also recognise Ag bound
to MHC [59–61]. A behaviour of NK cells, which shows that their surface receptors are tuned to
grasp abrupt changes in the stimulus that they receive instead of the absolute level of stimulus,
is proposed as the “discontinuity theory of immunity” [62, 63]. This theory can be supported by
the fact that when infected cells manage to escape the surveillance of B and cytotoxic T cells, are
being attacked by (NK) cells.
The functions of B and T cells are presented in Figure 1.3. While B cells can access Ag in the
extracellular environment, they fail to detect intracellular pathogens, such as viruses or bacteria.
Thus, through the production of specific antibodies, B cells support the extracellular defence.
T cells on the other hand, have to scan the surfaces of APCs, bind to the presented Ag, and
subsequently get activated in order to perform their respective tasks, cytotoxic T cells to kill and
helper T cells to boost B and cytotoxic T cell function as well as recruit other immune cells. In
contrast to B cells, T cells cannot recognize extracellular and soluble antigen, but only processed
antigen, presented by APCs.
In this thesis, I will focus on the interactions between T cells and APCs during antigen recog-
nition. This process leads to the reorganization of the surface molecules of these cells resulting in
the appearance of a characteristic pattern known as immunological synapse (IS). The IS pattern
formation is of great importance for T cell activation. Here, I will focus on the mechanisms leading
to the emergence of different, characteristic IS patterns.
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Figure 1.1: The organs of the immune system. Skin, mucous and membranes block the majority
of pathogens to enter the body. When the first barrier falls, the rest of the organs, thymous, bone
marrow, lymph nodes, tonsils and spleen, produce and train immune cells. Figure taken from: US
Department of Health and Human Services, NIH, URL: https://tinyurl.com/y78ejau3.
Figure 1.2: The cell types of innate and adaptive immune system. Adaptive immune responses
come in the forms of humoral and cellular immunity. Figure taken from: Oxford Immunotec, URL:
http://www.oxfordimmunotec.com/international/science/technology-2.
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Figure 1.3: Functions and interactions of the immune cells during an adaptive immune response.
Upon antigen uptake, B cells can get activated and produce memory and plasma cells, which defend
against extracellular pathogens. During antigen presentation by APCs, cytotoxic and helper T cells
get activated. Cytotoxic T cells defend against intracellular pathogens, whereas helper T cells boost
the effector function of B and cytotoxic T cells. Figure taken from: University of Leicester, as was
adapted from Biology, 8th Edition, Campbell and Reece, 2008 [64], URL: https://www2.le.ac.
uk/projects/vgec/highereducation/topics/microbial-genetics-1/vaccines-1.
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1.2 The immunological synapse
Formation of the immunological synapse. Dendritic cells (DCs), and more generally APCs,
collect antigen roaming the body by taking up large amounts of fluid and engulfing host or
pathogenic particles. They degrade pathogen proteins into peptides which in turn bind to MHC
complexes and are presented at the surface of the cells as these APCs move toward the lymph
nodes. In lymph nodes, they come into contact with thousands of naive T cells. Naive T cells are
the ones that were never in contact with antigen before (antigen inexperienced). In this way, the
T cells carrying TCRs become antigen specific which in turn leads to T cell proliferation. These T
cells then exit the lymph node and migrate either to the site of infection via the blood stream or
to the B cell follicles. The T cells that move to the site of infection will on one hand start killing,
in the case of cytotoxic T cells (CD8 T cells), or on the other hand, boost and coordinate other
cells to perform the killing and other immune compartments to clear the pathogen, in which case
they are called helper T cells (CD4). The phenotype of the T cells depends on the signals received
by the interactions with APCs in the thymus. In the particular case of antibody responses, B and
T cells need to meet in follicles and germinal centres, where T cells propagate important signals
to resident B cells. These signals define the fate of B cells, by either leading to B cell selection and
consequent high affinity antibody generation or B cell death. The interaction of a T cell with an
APC, i.e. B cell, dendritic cell, macrophage etc., is depicted in Figure 1.4.
Therefore, it begins to become obvious that antigen recognition by T cells is a key event during
an immune response. During the antigen recognition process T cells come in close contact with DCs,
B cells or in general professional APCs, i.e. APCs that present the peptide antigen bound to MHC
complexes of class II (Figure 1.4). TCRs search the APC surface for the presented antigen, which
are annotated as pMHC. Once the initial binding events happen, additional molecules bind their
respective ligands. One characteristic example is the lymphocyte function associated antigen-1
(LFA-1) which is a cell adhesion molecule and binds to intercellular adhesion molecule-1 (ICAM-
1), present on the APC surface [65, 66]. This process leads to the stabilization of the contact
interface and the re-organization of the surface molecules into the characteristic pattern known as
the immunological synapse (IS). Therefore, the IS is a dynamic cell-cell interface with binding of
molecules, spatial activation of signaling pathways and reorganization of the cytoskeleton.
It was initially observed that TCR bind to pMHC molecules, the term TCR-pMHC complexes
will be used. TCR-pMHC accumulate in the center of the contact region between the two inter-
acting cells [68, 69]. This region was named central supramolecular activation cluster or cSMAC.
This central TCR-pMHC region is surrounded by a ring of LFA-1-ICAM-1 called the peripheral
SMAC (pSMAC). There are many more molecules and receptors taking part in the process of
this dynamic pattern formation, such us CD4/CD8 which define the function of the T cell (helper
or cytotoxic T cells respectively), the costimulatory molecules CD28 and CTLA4 which compete
for the same ligands, CD80 and CD86, that also reside in the cSMAC, while other characteristic
examples include CD2 molecules on T cells that bind to CD58 in humans and CD48 in rodents and
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Figure 1.4: The interaction of an engineered T cell (red) with an antigen presenting cell (blue).
This interaction leads to the recruitment of signaling molecules such as ZAP70 (green) to the
contact interface. Figure taken from : Vale’s Lab URL: https://valelab.ucsf.edu/, as created
for the publication: James and Vale, Nature, 487, 64-69, 2012, DOI: https://doi.org/10.1038/
nature11220 [67].
the CD45 molecules for which there is no discovered ligand, that accumulate to the outer pSMAC
region, referred as distal SMAC (dSMAC) [70]. The pattern depicted in Figure 1.5, is the widely
studied immunological synapse (IS), also known as “bull’s eye” pattern.
Proposed mechanisms behind immunological synapse formation This characteristic IS
structure impacts on T cell activation, signaling and fate decision [71–78]. A lot of attention has
been placed toward understanding the mechanisms behind the surface molecules re-organization
which leads to characteristic IS formation [79–83]. During early time points of IS formation,
the specific TCRs which are bound to pMHC, form islands known as TCR-pMHC microclusters.
The contact interface is stabilized by integrin complexes, formed between LFA-1 and ICAM-1
molecules. These complexes assist in the adhesion between the two interacting cells. TCR-pMHC
microclusters move to the central region of the contact interface, while LFA-1-ICAM-1 complexes
encircle these microclusters. Later, the two kinds of complexes completely segregate from each
other and form two distinct areas in the synapse: the TCR-pMHC cSMAC and the LFA-1-ICAM-











Figure 1.5: The accumulation of different free and bound molecules in different regions of the
contact interface between T cells and APCs.
1 pSMAC [79]. The third, outer ring called dSMAC consists of other molecules and complexes,
which are excluded from the central and peripheral regions. Of course, many more molecules are
part of an IS, and they may reside to one of the three regions.
It has to be noted that the physiological interaction between two immune cells harbors very
complex mechanisms that are hard to study. The interacting cells build a complex 3D interface
with undulating membranes [84–88]. The difficulty of analysing and imaging the real life 3D cell-
cell contact led scientists to construct artificial systems, which try to mimic it. One such example
is the supported lipid bilayer (SLB). This system was developed to mimic cell membranes and
tissue [89, 90]. In the study of the IS, SLBs are widely utilized since they offer an ideal setting
for optical observation by microscope, such as total internal reflection (TIRFM) [91,92], and more
recently stochastic optical reconstruction (STORM) microscopy [93,94].
SLBs are coated with molecules which are laterally mobile. In this way, when the receptors of
the T cell bind to their ligands on the artificial APC (i.e. the SLB), the IS can still be reproduced
(Figure 1.6). Experimentalists have used this technique to observe how TCR-pMHC and LFA-1-
ICAM-1 accumulate to their respective regions at the later time points of the IS formation. An
obvious drawback of this technique is the absence of the APC, whose membrane is also dynamically
changing [95], similar to T cells. These dynamic changes may also assist TCR-pMHC central
accumulation or even lead to different patterns in the cell-cell junction, as observed for germinal
center B cell synapses by Nowosad et al. [96].
But what are the mechanisms that lead to TCR-pMHC microcluster formation? And how do
the microclusters accumulate in the central area of the contact region? The length of TCR-pMHC
complex spans at around 13 nm, whereas LFA-1-ICAM-1 complexes can be around 45 nm in length.
When TCR-pMHC complexes form, they tend to bring the two interacting cells very close to each
other. Thus, the longer LFA-1-ICAM-1 complexes don’t fit in these “close” contact areas. In
these regions, high membrane tension occurs which leads to membrane bending, and consequently
to steric exclusion of these two types of complexes (Figure 1.6). Similarly, other molecules can
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be clustered and segregate from one another due to their size [68, 97, 98]. This is referred to as
size-based segregation (SBS). There might be additional mechanisms that can lead to exclusion
of molecules from certain areas of the IS. One such example is the proposed kinetic segregation
model (KSM) [99]. This model suggests that molecules, such as CD45, can get excluded due to
intracellular signaling events. The ability of CD45 to interfere with the intracellular tail of TCR
and alter its signaling have led to proposition of this exclusion mechanism. The steric exclusion or
the exclusion due to KSM though are not able to explain alone the accumulation of the different
interacting molecules to one of the three different IS regions, central, peripheral and distal SMAC
(Figure 1.5). Therefore, biologists tried to shed light on the driving forces behind the characteristic
patterns observed.
The initial experimental observations focused on the movement of TCR-pMHC complexes,
since they are the most important players of T cell activation. It is observed that during antigen
recognition, there is a large scale reorganisation of the T cell actin cytoskeleton [101–104]. Actin
activation leads to T cell spreading on top of the APC, and at the same time there is continuous
polymerization leading to the formation of actin filaments (F-actin). The actin filaments form
bundles and move from the periphery of the cell-cell contact surface toward the center of it. In
the pSMAC region, F-actin filaments interact with myosin IIa molecules and are reorganized into
concentric arcs. The continuous F-actin polymerization at the periphery pushes these arcs toward
the cSMAC where it depolymerizes (Figures 1.7 & 1.8) [104–107]. This continuous flow of F-
actin arcs is believed to be the driving mechanism of TCR-pMHC accumulation in the cSMAC by
interacting with the intracellular tails of bound TCR molecules, pulling them toward the central
region and finally depositing them in the cSMAC [100,104,108–114].
In order to prove this theory, DeMond et al performed experiments with mazes of barriers on
the SLB surface and showed that TCR-pMHC movement is based on frictional coupling to F-actin
centripetal flow [100]. TCR-pMHC microclusters in Jurkat T cells are shown to be transported
in the IS due the retrograde flow of F-actin and the contraction of actomyosin-II arcs (Figure
1.8) [105, 107, 115]. Moreover, TCR microclusters and the actomyosin arcs were found to travel
together at a similar speed [104].
Additionally to TCR-pMHC, it has been observed that the F-actin flow in the IS drives the
spatial organization of LFA-1-ICAM-1 complexes. This process leads to the opening of the in-
tracellular tail of LFA-1 in regions close to the cSMAC, a process called affinity maturation of
LFA-1, and leads to LFA-1 activation [104, 115–117]. Furthermore, F-actin polymerization and
retrograde flow have been shown to be critical for the movement of sinaling microcluster [102,112]
and PLCγ1 signaling [111]. In the case of cytotoxic T and NK cells, actin depletion in the center
of the IS is shown to lead the event of granule secretion in order to perform killing of the infected
target cell [43,118,119]. It is also shown that the formation of an IS improves the killing efficiency
by three to four times, compared to cytotoxic T cells that failed to form IS with infected target
cells [120].
A centrally directed transport is likely not restricted to TCR-pMHC and LFA-1-ICAM-1 com-
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Figure 1.6: T cell-SLB system. SLB is coated with laterally mobile molecules, such as pMHC and
ICAM-1. T cell roams the SLB surface and upon TCR-pMHC binding comes in close contact. The
longer LFA-1-ICAM-1 complexes forming do not fit in the close contact regions, and membrane
bending occurs, which leads to steric exclusion between TCR-pMHC and LFA-1-ICAM-1 com-
plexes. The SLB system has also been used to study geometrically repatterned synapses, either
for signaling [71] or for localization mechanism studies [100]. Figure taken from: Mossman et al.,
Science, 310, 1191-1193, 2005, DOI: DOI:10.1126/science.1119238, [71].
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Figure 1.7: The F-actin network during IS formation. Left: F-actin filaments characteristically
show the three IS regions, the dSMAC where bundles of F-actin appear, the pSMAC where the
concentric arcs are observed and finally, the cSMAC void of F-actin. Right: The F-actin filaments
(red) interact with myosin IIa molecules (green) in the pSMAC and are re-oriented into concentric
arcs, which are depolymerized in the cSMAC region. Figure taken from: Murugesan et al., J Cell
Biol, 215, 383-399, 2016, DOI: DOI:10.1083/jcb.201603080 [104].
plexes, and it is not clear whether other molecules in the IS are also coupled to F-actin. This is
one of the questions I will try to answer in this work. For the sake of simplicity, and to be able
to use the majority of the experimental data, the in silico investigation of the IS dynamics and
mechanisms leading to formation of different characteristic patterns will be based on observations
made on SLBs.
The actin cytoskeleton except for its central role in IS pattern formation, is shown to affect TCR
signaling too. Characteristic polymerized actin structures in the sites of TCR-pMHC engagement,
called F-actin foci, are shown to recruit and phosphorylate PLCγ, a critical point of TCR signaling
[121].
Apart from the dynamics of the F-actin cytoskeleton, recent advances in imaging started to
elucidate the importance of microrubules in IS formation. Microtubules are microscopic, hollow
tubes formed by the polymerization of tubulin proteins. They are responsible for the cell shape and
the organization of the cell’s organelles [122]. Some of their roles include cell division, movement
and transport of materials within the cell. The microtubules are organized by the microtubule or-
ganization center, or MTOC. During IS formation, the MTOC re-organizes the T cell microtubules
on top of the IS region (Figure 1.9a) [123–126]. It has been observed that TCR-pMHC microclus-
ters move along microtubules (Figure 1.9b), while inhibition of the microtubule organization, leads
to impaired IS pattern [127–129]. Additionally, microtubules are considered important for T cell
signaling by assisting calcium flux [123,130–132]. Therefore, it is clear that the entire cytoskeleton
is taking part, if not being completely responsible, for the organization of the surface molecules
during IS formation.
Functions of the immunological synapse. As it was discussed so far, the formation of the
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Figure 1.8: Organization of actin dynamics in the IS. Actin polymerizes at the periphery of the IS,
and travels toward the center of the IS. In the pSMAC region, actin reorganizes into concentric arcs
with the help of myosin II molecules and continues toward the cSMAC, where it depolymerizes. In
the cSMAC accumulation of TCR-pMHC complexes together with many signaling molecules (gold
spheres) is observed. Figure taken from: Comrie and Burkhardt, Frontiers in immunology, 7, 68,
2016, DOI: https://doi.org/10.3389/fimmu.2016.00068 [107].
a b
Figure 1.9: Microtubule organization during IS formation. (a) TCR-pMHC microclusters attach
to dynein motors which in turn are attached to actin and microtubules. In this way TCR-pMHC
microclusters are transported to the center of the IS. (b) MTOC organizes microtubules, which are
attached to signaling TCR-pMHC microclusters. Figure taken from: (a) Lou et al.,Front Cell Dev.
Biol., 4, 77, 2016, DOI: https://doi.org/10.3389/fcell.2016.00077 [124]. (b) Hashimoto-
Tane et al., Immunity, 34, 919-931, 2011, DOI: https://doi.org/10.1016/j.immuni.2011.05.
012 [128].
IS is important for many different reasons, such as killing of infected cells or boosting the functions
of other immune cells. In order to achieve such behaviour, T cells need to receive the appropriate
signals from the APCs they come in contact with. During the IS formation, very complex signaling
cascades in the T cell get activated. There are several theories of how the T cell receptor gets acti-
vated. CD45 has a double effect on TCR signaling, through interaction with the Src family kinase
Lck [133]. CD45 controls the activation of p56lck, by either phosphorylating the Y505 site which
leads to closed Lck conformation and therefore signal inhibition, or by phosphorylating the Y394
site, which results in the opening of Lck and consequently signal amplification [134, 135]. Davis
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and Merwe suggested that the exclusion of CD45 molecules from TCR-pMHC sites results in signal
amplification, which can lead to T cell activation [99], in a model called kinetic segregation (KS).
It is also shown that inhibition of an enzyme known as tyrosine protein kinase Csk or c-terminal
Src kinase, can trigger TCR signaling [136–138]. Others suggested that during TCR and pMHC
interactions, conformational changes happening on TCR molecules can affect signaling [139–143].
Additionally, it has been observed that TCRs respond to forces induced by catch bonds or by the
actin network interactions, and increase the interaction strength with pMHCs, contributing to sig-
nal amplification [144]. Signaling cascades starting from triggered TCR molecules consist of a very
complex network of interacting receptors, kinases, enzymes, transcription factors, phosphatases
and many more (Figure 1.10). All these molecules and mechanisms are orchestrated by the re-
ceived signals during antigen recognition which eventually result in the desired effector function of
the T cell [131,145–149].
There are many interesting mechanisms by which the two interacting cells communicate during
the IS formation. On the T cell side, engulfing of interacting TCR-pMHC complexes and endocy-
tosing them leads to three key events. The internalized active TCR together with the antigen can
lead to additional intracellular signaling (Figure 1.11) [150,151]. The complex can be also degraded
or recycled to the surface of the T cell. The T cell can also engulf TCRs into microvesicles. These
microvesicles are then released in the cell-cell junctions, and can be phagocytosed by the APC
(Figure 1.11) [152–154]. The internalized TCRs can then interact with intracellular pMHC, which
enhances APC signaling. These complex trafficking dynamics, as well as recruitment of molecules
to the IS from the rest of the cell surface were not considered in the development of the model,
which will be presented in the following sections.
Importance of the immunological synapse. IS formation is an important step for the
body’s defence against pathogens. There are defects though in IS formation. Synapses can show
non-conventional patterns and it is not clear how this affects TCR signaling and T cell activation.
The stable, radially symmetric synapses are considered as the normal cases (Figure 1.12 (top)).
There are cases where the symmetry brakes and the T cells are moving on top of the APC or SLB
surfaces. In these cases, the lamellipodium takes the place of the dSMAC and is the leading edge of
the moving T cell. The lamella region takes over the role of the pSMAC, with adhesion molecules
residing there and the uropod is a kind of moving cSMAC. In addition, the microtubule organization
changes drastically (Figure 1.12 (bottom)). Synapses like this are known as kinapses [155–159].
Schubert et al. showed that T cells formed normal synapses with influenza-infected cells, but the
IS formation was impaired in the case of multiple sclerosis (MS) and type-1 diabetes (T1D) [160].
They quantified the effectiveness of the IS formation for different T cell clones (Figure 1.13 (top
line)) and showed that in the cases of MS and T1D synapses failed to form (Figure 1.13 (yellow
and beige blocks)). These two examples, MS and T1D, elucidate the importance of the synapse,
since impaired formation and function can be a leading cause for autoimmune diseases.
In the case of breast cancer, it has been observed that T cells are highly motile in the tumour
region. This means that the interactions with the tumour cells are transient and therefore the T



















































































































































Figure 1.10: T cell signaling pathways, include an enormous variety of receptors, kinases, phosph-
tases, enzymes, transcription factors and many more. Figure taken from: Cell Signaling Technol-
ogy, URL: https://www.cellsignal.com.
cells form kinapses instead of synapses. In these cases, tumours continue to grow and there is high
metastasis potential. Techniques to combine T cell anti-CTLA-4 treatment, a common treatment
against different types of cancer [161–164], with radiation therapy showed that T cells are arrested
in the tumour area, forming stable synapses. This T cell behaviour led to tumour shrinkage and
low metastasis potential [165].
To conclude this part, experiments have shown the importance of immunological synapse for-
mation in many different settings, such as viral infections, autoimmune diseases and cancer. Both
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Figure 1.11: Communication of the two interacting cell, T cell and APC, during IS formation.
When TCR-pMHC complexes are endocytosed by the T cell, the antigen is being processed which
leads to (i) signaling initiation, (ii) degradation of it or (iii) recycling back to the surface. Simi-
larly, TCR-pMHC complexes can get endocytosed by the APC. Additionally, the T cell generates
microvesicles which contain T cell receptors. The microvesicles are released in the IS region and
taken up by the APC, which again leads to activation of signaling cascades. Figure taken from:
Finetti et al., F1000Research, 6, 2017 , DOI: 10.12688/f1000research.11944.1 [151].
the interacting cells, T cell and APC (macrophage, dendritic cell or B cell) exchange information
which leads to different behaviours. In T cells, the formation of the IS leads to activation, pro-
liferation, cytokine and lytic granule secretion, apoptosis, differentiation and TCR signaling. The
transmitted signals from the T cell lead to boosted APC functions, such as killing in the case of
macrophages and production of antibodies in the case of B cells. Given these conclusions, it is
not surprising that IS formation is so widely studied, not only from biologists but also from the
mathematical and physical community, as I will discuss in the following section.
1.3 Modeling of immunological synapse formation
Apart from biologists, many scientists in the fields of physics and mathematics showed great
interest in understanding a system as complex as IS formation. Different modeling approaches
have been developed to understand the IS spatial formation from mechanistic forces, with the
majority focusing on the mechanisms of microcluster formation. There are different approaches,
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Figure 1.12: Synapse versus kinapse formation. Synapses are radially symmetric whereas in ki-
napses the symmetry is lost and the T cell moves in the direction of the arrow. The organization
of microtubules is also drastically changing between the two cases. Figure taken from: Dustin,
Curr opin cell biol, 19, 529-533, 2007 , DOI: 10.1016/j.ceb.2007.08.003 [155].
including partial differential equation (PDE), statistical mechanics and agent-based models, which
I am going to discuss below.
Partial differential equation models. Qi et al. established a PDE model in order to examine
whether the formation of the synapse could be driven by self-assembly involving extracellular
receptor interactions and membrane bending [166, 167]. A set of reaction diffusion equations
coupled to one that describes potential motion toward a free energy minimum for the membrane
shape changes constitute the model [167]. In this work, the authors concluded that the formation
of the IS may simply emerge from self-assembly processes. This model could be extended to test
different systems, such as multiple different peptides on the APC surface or NK cell synapses,
instead of T lymphocytes, with the limitation that receptors and ligands were embedded into
opposed, deformable membranes whose properties could be derived from the cytoskeleton [168].
Burroughs and Wu¨lfing created another PDE model, trying to prove that the mechanism of IS
formation is supported by the length difference in the different kinds of complexes (TCR-pMHC
and LFA-1-ICAM-1), namely the size-based segregation (SBS), by incorporating reaction kinetics,
thermodynamics, and elasticity of the complexes and the membranes [169]. They concluded that
the different bond lengths induce a significant contribution to the free energy of the interaction,
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Figure 1.13: Efficiency of IS formation for different T cell clones (top line) in different settings, such
as influenza infected cells, multiple sclerosis (MS) and type 1 diabetes (T1D). The stability and
radial symmetry of the IS is defined as a response value. In red and orange the formed synapses
are considered very good, whereas yellow and beige show defects in the IS patterns. Figure taken
from: Schubert et al., JEM, 209, 335-352, 2012 , DOI: 10.1084/jem.20111485 [160].
which means that the membrane deformations are important for the dynamics of IS formation.
More recently, Carlson and Mahadevan introduced an updated PDE model [170]. This model
takes into account the membrane mechanics, the protein binding kinetics and motion, as well as
the fluid flow in the synaptic cleft in the contact interface between the two interacting cells. In
comparison with experimental data, the authors were able to show that passive elastohydrody-
namics and protein binding kinetics are able to describe the formation and organization of protein
clusters. Interestingly, this model does not invoke active cytoskeletal transport processes.
In all the above models, size-based segregation (SBS) [82] explained the TCR microcluster
formation, but was not sufficient to confer the formation of a “bull’s” eye pattern. Additional
assumptions were required for the reproduction of the TCR-pMHC cSMAC formation in accordance
with the experimental observations [68].
Statistical mechanics models. Weikl et al. introduced a statistical mechanics model [171,
172], which includes thermal fluctuations. This model incorporates different forces, including
membrane deformations, in an energy-dependent manner, which describes the global configuration
of densities at each site of the lattice. Densities are locally updated by virtue of a Monte Carlo
simulation and depend on the variation in the free energy. An extension of this model would be to
explicitly distinguish agents, which would not change the outcome of the simulations. The authors
observe that the “bull’s eye” pattern is initially reversed, with TCR-pMHC complexes forming at
the periphery of the contact region, while LFA-1-ICAM-1 complexes are present in the cSMAC.
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They confirm the findings of [166, 167], but in contrast to other theoretical studies, this model
needs the cytoskeletal transport process, in order to obtain the final pattern of the IS.
Lattice gas model. A recently developed lattice gas model containing three types of sites,
empty sites, mobile TCR-pMHC sites and immobile sites representing the F-actin sites respectively,
investigates only the aggregation of TCR-pMHC complexes to the central IS region. The model
concludes that the TCR-pMHC cSMAC accumulation is driven by a combination of membrane
mediated attraction, actin retrograde flow and transport of dynein motors [173]. This model
though lacks the presence of the essential adhesion complexes, LFA-1-ICAM-1.
Agent-based models. The basis of an agent-based model is that individual interacting agents
represent molecules that form patterns in the IS and follow specific rules. Figge and Meyer-
Hermann formulated an agent-based model taking into account the motion and interactions of
individual agents/molecules, as well as the binding kinetics of TCR-pMHC and LFA-1-ICAM-1
complexes [174, 175]. The authors discussed the differences between a long-range, attractive force
between TCR-pMHC complexes versus a centrally directed transport of these molecules. Their
computer simulations [174] were based on the geometrically re-patterned experimental observations
introduced by Mossman et al. [71]. In this setting, chromium barriers that block the diffusion
of molecules on SLBs, showed that signaling can be sustained if the TCR-pMHC microclusters
are blocked form reaching the cSMAC. The authors’ predictions where tested experimentally by
[100], by introducing mazes of barriers on SLBs and monitoring TCR-pMHC movements. The
corresponding experimental results suggested a coordinated centripetal transport of TCRs linked to
the centripetal cortical actin flow. They also showed that the diversity of molecular patterns, such
as dynamic and multifocal structures, is directly related to the TCR-pMHC binding affinity [175].
Similar methodology was used by [176, 177]. In this case, the B cell-APC interaction was
modeled. The authors investigated whether the transport of molecules by the cytoskeleton toward
the center is a potential mechanism for IS formation. The working hypothesis of this model was
investigated with a Monte-Carlo approach with biased centrally directed diffusion of the complexes.
This model reproduces the experimentally observed IS for realistic time and affinity levels.
These above mentioned models were limited to microcluster formation and central forces on
the TCRs and did not investigate the effect of actin on other functional molecules.
In the following chapters, I will introduce a new agent-based model, which takes into account
SBS, binding kinetics and centrally directed motion due to F-actin coupling of complexes. I will
discuss potential mechanisms for the localization of a variety of molecules, which are important
for T cell activation, signaling, function and fate decision.
Chapter 2




Immunological synapses (IS) are complex three dimensional (3D) T cell-Antigen presenting cell
(APC) junctions that involve many molecular interactions leading to the formation of characteristic
spatial patterns. In order to investigate their formation dynamics, biologists produced artificial
systems where APCs are being replaced by Supported Lipid Bilayers (SLBs) [79]. SLBs are two
dimensional (2D) surfaces coated with laterally mobile and fluorescently tagged molecules, which
act as ligands for the receptors on T cells. This set-up allowed for the usage of confocal (CF)
[178], total internal reflection fluorescence (TIRFM) [91, 92] and more recently stochastic optical
reconstruction (STORM) [93,94] microscopy, leading to a more detailed insight of the T cell-SLB
contact interface in general and the molecular movement and localization more specifically. Another
advantage of the SLB system is that the number of molecules in the bilayer and the number of
interactions with receptors can be quantified, or even more important, can be controlled.
2.2 Setting-up the T cell and SLB surfaces
I developed an agent-based model based on the simplified T cell-SLB experimental set-up [79].
Initially, a representation of the two interacting surfaces was needed. This is accomplished by
creating a lattice for both of them [179]. I further simplified the experimental setting, implementing
both lattices in 2D, where each lattice is represented as a square mesh (Figure 2.1). The nodes
of these meshes are called gridpoints, which are initially empty. The lattice constant, α = 70 nm,
represents the closest distance between two neighboring gridpoints [175, 179, 180]. This constant
35
36 CHAPTER 2. AGENT-BASED MODEL
is varied between α = 100 nm and α = 17 nm, in order to investigate IS formation within the
resolution range of currently used microscopy techniques, i.e. TIRFM at ' 100 nm and STORM
at ' 20 nm. The gridpoints outside a radius R > 4.9µm from the central point of the two lattices
are blocked as inaccessible by agents. In this way, the initial square lattice, is transformed into a
circular surface, representing an established contact surface between the two interacting cells.
For the two in silico cells, I used a Moore neighborhood, meaning that each gridpoint on
the lattices has eight neighbors, four on the vertical and horizontal direction, called the “nearest
neighbors”, and the other four, the diagonal neighbors, which are the “next-nearest neighbors”.
The movement of the agents that will be introduced later will be confined to these gridpoints [179].
Of course there are other possible approaches to represent the two surfaces. On the one hand, a
similar lattice to the one used here, but with movement being restricted only to the four nearest
neighbors (von Neumann neighborhood). In this case, a diagonal movement would require that an
agent performs two moves, horizontal and then vertical or vertical and then horizontal, compared
to the one diagonal movement of the Moore neighborhood. In such a case, more computational
time would be required for the same movement. On the other hand, one could even use a square
plane where the agents can move in any random direction. This case would require the use of a
collision detection algorithm. Therefore, the usage of square lattices with Moore neighborhoods has
the advantage of being computationally fast but requires some measures that repair the artificial
discretization of space which bears the risk of generating artifacts.
2.3 Introducing the agents
Now that the in silico cell surfaces were ready, I had to introduce the agents. These agents will
represent the different kinds of molecules that are present on the surface of each cell. The agents
are randomly distributed on the gridpoints, while each gridpoint can acquire one and only one
agent. The densities used for each agent are taken from literature and can be found in Table 2.1.
2.4 Agent diffusion
Molecules diffuse on the surface of cells due to thermally induced stochastic motion, meaning that
it is a random process that can happen toward any direction. However, in the in silico setting,
diffusion can only happen toward one of the eight “nearest” and “next-nearest” neighbors, due to
the Moore neighborhood representation (Figure 2.1). Therefore, a random direction generator will
choose one of these neighbors in a probabilistic manner, provided the selected position is empty,
such that the movement can be accomplished. Diffusion is represented as a random walk in the
lattice, where the probability to move is defined as the ratio of the simulation time step to the time
an agent needs to diffuse on a neighboring gridpoint on the 2D lattice with a type-specific diffusion
constant DX [175, 179]. Here X denotes one of the molecules or complexes under consideration.
The formation of complexes will be discussed in detail later.
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Since the diagonal movements are longer than the horizontal or vertical ones, a diagonally
moving agent will cover bigger distance than an agent moving on the horizontal or vertical direction
in a specific time interval. In order to take into account the distance between different gridpoints,
the probabilities of moving to a diagonal neighbor is reduced by the geometrical factor of 1/
√
2
[174,175]. Further, in order to account for adhesive behaviours between agents, a phenomenological
adhesive factor, f(Nnn), which further reduces the diffusion probability is introduced to the model
[175,179], given by:
f(Nnn) =
1/(1 +Nnn), Nnn ≤ 40, Nnn > 4 ,
where Nnn is the actual number of “nearest neighbors” occupied by the same kind of agent with
the agent under investigation. One such example of adhesive force could be the cross-linking of
engaged TCR molecules, where their intracellular tails get entangled [181]. Finally, the maximum
estimated simulation time step is given by the ratio of the lattice constant squared, α2, to the
diffusion coefficient of a free molecule, Dm, where m denotes an arbitrary molecule, and should be
smaller than t > 0.0012 seconds.
2.5 Agents/Molecules present in the IS
The agents studied in this work, are considered some of the most important molecules for T cell
activation, function and fate decision, and include the following, on the T cell lattice together with
their respective ligand on the SLB lattice:
(a) T cell receptor (TCR), which binds to peptide antigen bound to major histocompatibility
complexes (pMHC).
(b) Lymphocyte function-associated antigen 1 (LFA-1), which binds to intercellular adhesion
molecule 1 (ICAM-1).
(c) Cluster of differentiation 28 (CD28), which binds CD80 and CD86. Here only CD80 is
considered in order to be in accordance with experimental settings.
(d) Cluster of differentiation 2 (CD2), also known as T cell surface antigen, LFA-2, LFA-3 recep-
tor, erythrocyte receptor and rosette receptor, which binds to CD58 in humans and CD48 in
rodents.
(e) Cluster of differentiation 45 (CD45), originally called leukocyte common antigen (LCA),
which does not have a known ligand.
The association, dissociation rates, sizes, interactions are presented in Table 2.1, together with
other characteristic parameters of the model, such as diffusion constants, lattice size and agent
densities.
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Name Parameter Value
Radius of contact region R (µm) 4.9
Lattice constant a (µm) 0.07
Free molecule diffusion constant Dm (µm
2/s) 0.10
Complex diffusion constant Dc (µm
2/s) 0.06
Size of TCR-pMHC (nm) 12
Size of LFA-1-ICAM-1 (nm) 45
Size of CD28-CD80 (nm) 10
Size of CD2-CD58 (nm) 11
Size of CD28-CD80 (nm) 10
Size of CD45 (nm) 45
Radius of SBS between TCR-pMHC and LFA-1-ICAM-1 RSBS,TM−LI (µm) 0.425
Weight of SBS WSBS,TM−LI −1.0
Radius of SBS between CD28-CD80 and LFA-1-ICAM-1 RSBS,CC−LI (µm) 0.425
Weight of SBS WSBS,CC−LI −1.0
Radius of SBS between CD28-CD80 and TCR-pMHC RSBS,CC−TM (µm) 0.000− 0.210
Weight of SBS WSBS,CC−TM (−1.0, 0.0)
Radius of SBS between CD2-CD58 and LFA-1-ICAM-1 RSBS,CD2C−LI (µm) 0.425
Weight of SBS WSBS,CD2C−LI −1.0
Radius of Attraction between CD2-CD58 and CD2-CD58 RAtt,Self (µm) 0.00− 0.35
Weight of Attraction WAtt,Self 0.2− 1.0
Radius of Attraction between CD2-CD58 and CD28-CD80 RCD2CD28 (µm) 0.00− 0.35
Weight of Attraction WCD2CD28 1.0
Dissociation rate TCR-pMHC koff,TM (1/s) 0.1
Association rate TCR-pMHC kon,TM (1/Ms) 2 × 104
Dissociation rate LFA-1-ICAM-1 koff,LI (1/s) 0.03
Association rate LFA-1-ICAM-1 kon,LI (1/Ms) 3 × 105
Dissociation rate CD28-CD80 koff,CC (1/s) 1.6
Association rate CD28-CD80 koff,CC (1/s) 4 × 105
Dissociation rate CD2-CD58 kon,CD2C (1/s) 4
Association rate CD2-CD58 koff,CD2C (1/Ms) 6 × 105
TCR-pMHC centrally directed force CTM 1.00
LFA-1-ICAM-1 centrally directed force CLI 0.06
CD28-CD80 centrally directed force CCC 0.20
CD2-CD58 centrally directed force CCD2C 0.00
Fraction of occupied gridpoints in T cell 30 − 80%
Fraction of occupied gridpoints in SLB/APC 30 − 80%
Fraction of TCR, pMHC 6%
Fraction of LFA-1, ICAM-1 15%
Fraction of CD28, CD80 7.5− 15%
Fraction of CD2, CD58 0.075− 36%
Table 2.1: Reference parameter values.
2.6. CHEMICAL KINETICS 39
2.6 Chemical kinetics
So far the two lattices are not interacting with each other, meaning that the two cells are not
interacting. These interactions happen when agents from the one lattice bind to agents on the other
lattice. This should happen in a way similar to real life, thus chemical kinetics were introduced
to the model. While molecules diffuse on the lattices, they are allowed to check the agent at the
exact same position on the opposite lattice. If the agent is the appropriate, a receptor-ligand
binding probability is formulated. This probability is based on the association rates for the specific
molecules under consideration, kon, Avogadro’s number, and the volume of the grid mesh where








On the other hand, the probability of unbinding a complex into free molecules is based on the








The association and dissociation rates are taken from literature for the different kinds of
molecules and complexes I will discuss throughout this work. When a complex diffuses, its two
agents (one on each lattice) need to move in the same direction, which happens less often, thus
the diffusion rate of the complexes is assumed lower than that of free molecules, Dc < Dm, where
c denotes complex and m molecule [179,180].
2.7 Complex interactions
In the forming immunological synapse, the membranes of the cells are highly undulating and in
addition, the sizes of the forming complexes are highly variable. The different complex sizes lead
to surface tension, which further leads to membrane bending. Despite the elasticity that the
complexes can have, membrane bending forces the longer complexes to segregate from the shorter
ones, only based on their sizes. This behaviour is called size-based segregation (SBS).
Now this rule must be applied to the agents, but because the whole model is in 2D, membrane
bending cannot be included. As a phenomenological approach, another way to impose membrane
bending is to model a repulsive force between the different kinds of complexes. This force is
modeled as a weighted vector from a complex toward all its interacting neighbors, within a radius
Rforce [175]. The weight of each vector, Wforce, represents the strength of the force relative to
diffusion, where negative weights represent repulsion and positive ones attraction. All vectors are
summed, and the resulting vector points to the direction of movement (Figure 2.1). The direction
is attributed to one of the eight neighbors, based on a probabilistic function explained in the
following section (Movement discretization) and in [179].
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2.8 Movement discretization
There are several options to convert the unit vector direction of a force into the movement to a
gridpoint, which bears the risk of introducing unphysiological biases into the simulation:
(a) As a first strategy, a rounding scheme can be used: If the final vector points from (x, y) to
a position (x + δ, y + ), the two coordinates are rounded to the closest integer leading to
δ,  = ±1 or δ,  = 0. This technique could be used in meshless lattices, but here the resulting
synapse formation is affected by the square mesh, and is not in accordance with experimental
observations [179].
(b) Another technique is to use the factor 1/
√
2, as was done for the probabilities to move
diagonally by diffusion, but now for the angle θ of the force. This technique allows choosing
a position with a higher chance of moving vertically or horizontally compared to diagonally.
Still though, the effect of a the square mesh on the lattice will be clearly visible and far away
from the experimental observations [179].
(c) The previous two methods are deterministic, meaning that if an agent followed the same force
for several time steps, it would move to the same direction of the eight possible neighbors
each time, which would make it follow a straight movement into a direction imposed by the
lattice rather than by the direction of the force vector. In order to avoid this problem, a new
function is introduced, which decides where an agent will move in a probabilistic manner.
This function gives the probability to move from (x, y) to a potential new position (x+δ, y+
), where δ,  = −1, 0, 1. For example, if the forces that act on a complex in position (x, y)
point to a position between 0 and 45 degrees, there are two options for the agent to move.
Either it will move to position (x+ 1, y) or to position (x+ 1, y + 1). Thus, the probability
of δ = 1 is P (δ = 1) = 1. On the other hand,  can either be  = 0 or  = 1.
The way to decide between the two options is to project the force vector to the base vectors
formed by the two possible movement vectors. It gives the ratio on how many times they
should be used in order to follow the direction of the force, on average. Here, it leads to
P ( = 1) =
sin(θ)
cos(θ)
= tan(θ). In accordance, if, for example, the vector of the forces points





The formula giving the probabilities for δ and  is depicted in Figure 2.2a, b and is derived
from the tangent and the cotangent of the angle θ, which is the angle of the force vector with
respect to the x−axis. Finally, as the diagonal movements cover more distance, and because
the ratio between diagonal and straight moves has to be kept, the probability to move by
forces is reduced from 1 to 1/L where L is the length of the “average movement vector”
generated by this method. It is following the unit vector force but its length depends on the
angle, Figure 2.2c [179].
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2.9 Centripetal transport of complexes
In recent years, the formation of a mature IS has been attributed to molecules binding to cortical
filamentous actin (F-actin). F-actin forms concentric arcs in the T cell during the antigen recogni-
tion process, which move symmetrically toward the center of the contact region. By contraction,
these arcs can pull the intracellular domains of different molecules, leading to the formation of
the characteristic IS pattern known as “bull’s eye” pattern [100, 104, 105, 115]. A new rule has
to be introduced to the model, in order to recapitulate this inward transport of molecules. For
simplicity, and since the model is in 2D, the transport of complexes by the centripetal contraction
of F-actin arcs is modeled as a centrally directed empirical force (Figure 2.1). This new force will
be added to the SBS force vector with weight CX > 0, where X denotes the specific complex. CX
now reflects the strength by which molecules bind to F-actin, or in other words, the strength of
the centripetal force exerted on complexes due to the coupling with F-actin.
2.10 F-actin foci model
F-actin foci are dynamically polymerized structures resulting from local nucleation of F-actin,
and appear at TCR-pMHC sites [112, 121]. For the implementation of the F-actin foci model,
a third square 2D lattice is created. This lattice represents the T cell membrane. As shown in
Figure 2.3, TCR-pMHC complexes from the T cell lattice can create F-actin nucleation points
on the F-actin lattice. In this way, the two lattices are now communicating and interacting with
each other. Similarly, nucleation points can get polymerized, called nucleation polymerized points,
if they colocalize with LFA-1-ICAM-1 complexes. In further presence of LFA-1-ICAM-1 in the
neighborhood, defined by Rneighborhood, around either nucleation or nucleation polymerized points,
polymerization of F-actin foci happens, creating polymerization points. These polymerization
points form clusters representing the experimentally observed F-actin foci.
This model will be implemented on the final chapter, where I will be discussing TCR cooperativ-
ity during pMHC amount titration. In this case, foci act as positive regulators of the probability
of TCR binding, allowing to simulate active modulation of the association rate of TCR-pMHC
complexes.
2.11 Exchange algorithm
In order to avoid artificial inhibition of motility by local crowdedness, a local exchange algorithm
was implemented [180, 182]: Agents that failed to move by active forces (SBS or actin coupling)
to an occupied node are stored in a list. At the end of each time step, the agents on this list retry
to perform the movement. If the target position is free, then the agent moves on it. If the target
position is occupied by an agent with a force pointing toward the moving agent, the two agents
are exchanged. Otherwise, the agent remains in its initial position.
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2.12 Optimization of simulation speed
To optimize the speed, all the agents are separately stored in a list, which is shuﬄed, and at each
time step, all the agents are picked in a random order and updated. Each of the steps described
above, i.e. diffusion, binding kinetics, interactions between complexes and centripetal transport,
are tested once per time step per agent.
2.13 Model implementation
The model is programmed using object-oriented programming in C++ language. The code is
separated in two classes: one representing the agents and, the other, the lattices including the
rules applied to these agents. The completion time of a simulation takes about 6-8 hours of CPU
time (using a 3.47 GHz CPU) for 30 minutes of IS formation. The random generator used is
mersenne twister engine (mt19937), and the IS plots were generated using the Qt framework.
2.14 Model readouts
Except for the visualization of the IS pattern using the Qt framework, the model allows more data
to be stored in text files for further analysis.
(a) Density plots. The density of complexes and molecules was computed inside equally spaced
concentric rings as the fraction of occupied grid points by each type of complex. The standard
deviation (SD) of at least n = 10 simulations is plotted. Absence of SD in density plots was
justified by the robustness of simulations.
(b) Localization plots. Utilizing the density plots, and by considering boundaries for each
one of the areas of the IS, central, peripheral and distal supramolecular activation clusters
(SMACs), the percentages of each molecule and complex in each SMAC are plotted.
(c) Radial distribution functions. The radial distribution function, RDF, (or pair correlation
function), describes the density as a function of distance from a reference particle. In this
study, I implemented the RDF as the local density of agents (complexes or molecules) inside
a ring of width dr, at a distance r from a reference particle, normalized by the total density
of the particle under consideration [180]. The plotted RDF represents the frequency of
finding a particle of a specific type in a particular distance from a reference particle. This
representation is useful to show the mean size of TCR-pMHC microclusters, the distribution
of LFA-1-ICAM-1 away from a TCR-pMHC microcluster, and the degree of colocalization of
CD28-CD80 and TCR-pMHC in microclusters.
(d) Agent colocalization. The model further calculates the amount of molecules or com-
plexes within a defined radius Rcol = 0.21µm. If a minimum number, min(X, Y ), of the
two different kinds of molecules or complexes, X and Y , is found, the model returns the
colocalization [180].
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(e) In situ dissociation constant. The model stores the density of the free and complexed
agents. The in situ dissociation constant, cellKD, is calculated by:
cellKD =
[Receptorfree][Ligandfree]
[Receptor − Ligandpair] , (2.3)
as was experimentally presented by Pielak et al. [183].
The presented agent-based simulations could also be implemented as a PDE model by treating
the IS on a macroscopic population level. I was choosing an agent-based model because this
approach allows to go down to the single molecule level, which might become relevant in small
structures and at high resolution. In this limit, agent-based approaches appear as the better
choice [180].












Figure 2.1: List of mechanisms included in the IS model. The membrane of the T cell (blue) and
the SLB (pink) carry molecules. Opposite molecules bind or unbind by chemical kinetics. Free
and complexed molecules move by diffusion or forces: centripetal forces reflecting actin coupling
and SBS representing the effect of membrane bending.
44 CHAPTER 2. AGENT-BASED MODEL
Probability for x variable Probability for y variable
Length of average movement
Figure 2.2: The probability functions for δ and  variables, for the movement of the agents. (a)
Probability function for x variable, given by ±1/ tan(θ), where θ is the angle of the vector force in
the x direction. (b) Probability function for y variable, given by ± tan(θ), where θ is the angle of







TCR + pMHC TCR-pMHC
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LFA-1 + ICAM-1 LFA-1-ICAM-1
kon
ko
Figure 2.3: Model for F-actin foci formation. TCR-pMHC binding leads to F-actin nucleation,
which in presence of LFA-1-ICAM-1 leads to polymerization of the nucleated actin. Consequently,





The formation of immune synapses (ISs) is a central process for antigen recognition by T cells.
The structure of the IS impacts on T cell activation, signaling, and fate decisions as I discussed
so far [68, 71–78]. For these reasons, a lot of attention has been placed toward understanding the
mechanisms of IS formation [79, 81, 82, 184]. During early IS formation, specific T cell receptors
(TCRs) bind to peptide-bound major histocompatibility complexes (pMHC) of either class I or
II and form islands of microclusters. Synapse formation and adhesion is stabilized by integrin
complexes, formed between lymphocyte function-associated antigen 1 (LFA-1) and intercellular
adhesion molecule 1 (ICAM-1). TCR-pMHC microclusters move to the central region of the
contact interface, while LFA-1-ICAM-1 complexes encircle these microclusters. Later, the two
kinds of complexes segregate from each other and form two distinct areas in the synapse: the
central supramolecular activation cluster (cSMAC) occupied by TCR-pMHC complexes and the
peripheral SMAC (pSMAC) formed by integrin complexes [79].
Together with the aforementioned molecules, T cells and APCs express hundreds of other
receptor and ligands, which in turn play important roles in T cell activation and effector function.
A characteristic example is the transmembrane protein phosphatase CD45. Interestingly, no ligand
has been described for CD45 on APCs so far. Therefore, CD45 molecules do not communicate
directly with the APC. Despite that, CD45 has been shown to exert a double effect on TCR
signaling, either by positively regulating T cell activation through the dephosphorylation of p56lck
and p59fyn [185–190], or by negatively regulating the autocatalytic tyrosine phosphorylation of src-
kinase molecules and their ability to dephosphorylate components of the T cell complex [191,192].
The double role of CD45 on TCR signaling comes with a specific localization. These molecules are
observed to be excluded from the forming TCR-pMHC microclusters and eventually are completely
excluded from the IS, and reside in the outer pSMAC region, called distal SMAC (dSMAC) [185].
Interestingly, there are reports suggesting that the exclusion of CD45 is not necessary in the case
of high affinity TCR-pMHC interactions, at least at the early times of TCR activation [193]. In
45
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this case too, CD45 slowly segregated from the sites of TCR-pMHC engagement. Therefore, it
becomes clear that the particular localization and dynamics of CD45 are relevant to understand
the regulation of TCR signaling in the synapse [108,194].
In this chapter, I will examine possible mechanisms for the localization of the four basic
molecules required for IS formation, namely TCR and LFA-1 on the T cell surface and pMHC
and ICAM-1 on the APC surface. In the forming IS pattern, CD45 molecules will be introduced
and I will try to shed light onto the mechanisms that lead to CD45 exclusion and the formation
of the dSMAC.
3.2 Formation of the Immunological Synapse
In order to understand the mechanisms driving the spatial organization of molecules in the IS, I
start from an agent-based model taking into account TCR, LFA-1, pMHC and ICAM-1 only [180].
Molecules are located in the two lattices representing the membranes of the two interacting cells.
Free molecules may bind to their cognate ligands on the opposite lattice and already formed
complexes can return to the free molecule state, according to their respective dissociation constants
(see Table 2.1) [175,179,180]. First, molecules and complexes move only according to diffusion. As
seen in Figure 3.1a, the diffusing complexes fail to form any particular pattern, and the IS region
consists of intermixed TCR-pMHC and LFA-1-ICAM-1 complexes. This is a result of ignoring the
bending of membrane due to lack of interactions between complexes.
It is known that TCR-pMHC and LFA-1-ICAM-1 have big differences in size, with TCR-pMHC
being around 12 nm in length while LFA-1-ICAM-1 complexes have a size of about 45 nm. This
size difference creates high tension in the regions where the smaller TCR-pMHC complexes reside,
which leads to membrane bending and consequently, steric exclusion of the bigger LFA-1-ICAM-
1. In order to phenomenologically represent the membrane bending in the two-dimensional (2D)
system, size-based segregation (SBS) was modeled as a repulsive force between two complexes of
different lengths [82]. The introduction of SBS generated TCR-pMHC microclusters, which failed
to merge into the central supramolucular activation cluster (cSMAC) Figure 3.1b, and did not
create the experimentally observed “bull’s eye” pattern. This suggests that additional forces are
needed for its formation.
A phenomenological centrally directed force was introduced into the model, which represents
coupling of molecules to actin, inducing a centripetal flow. The strength of the force reflects the
coupling strength to F-actin arcs. It was initially applied only to TCR-pMHC complexes Figure
3.1c [100,104,105,115]. Microclusters formed within the first minute of contact between the cells,
merged into bigger clusters, and finally formed the cSMAC Figure 3.1c. The mature synapse formed
at ten minutes and remained stable, in agreement with experimental results [79,108]. This in silico
framework recapitulates the major properties of the IS, and is suitable to further investigate the
properties of additional mechanisms and regulatory molecules.
In Figure 3.1d, the density of complexes was computed inside equally spaced rings as the
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fraction of occupied grid points by each type of complex. Here I observed the differences in the
distribution of TCR-pMHC and LFA-1-ICAM-1 complexes throughout the cell-cell junction, in
the three cases discussed above, (i) only diffusing complexes, (ii) addition of SBS and (iii) further
addition of TCR-pMHC centripetal force due to actin coupling. When the characteristic pattern
is formed, TCR-pMHC complexes reside in the central region of the IS, while LFA-1-ICAM-1 are
homogeneously distributed outside the cSMAC, forming peripheral SMAC (pSMAC).
The relative positioning of molecules can be quantitatively described using Radial Distribution
Functions (RDFs). The RDF between two types represents the frequency of finding a particle
of type 2 in a radial neighborhood of type 1 particles. The peak of the RDF of TCR-pMHC
complexes to themselves at 60 seconds reveals the formation of microclusters with a mean diameter
of d ' 0.3 (Figure 3.2a). This diameter increased and ultimately led to a cSMAC with a diameter
of d ' 2.0− 3.0µm at 600 seconds [180].
The RDF of LFA1-ICAM-1 complexes around TCR-pMHCs (Figure 3.2b) also reflects the
microclusters with d ' 1µm at 60 seconds, which evolve to larger structures of d ' 3 − 4µm at
600 seconds. These diameters are larger than those in the RDF of pairs of TCR-pMHC complexes,
which reflects the halo around the microclusters and the cSMAC. This predicted halo is also found
in experiments, and the model supports that this is a result of the membrane bending in these
regions [195].
3.3 LFA-1 coupling to F-actin results in a pSMAC gradient
toward the center of the IS
So far the model showed that the experimental observations of TCR-pMHC interacting with the
F-actin flow [100,104,105] can act as a mechanism for TCR-pMHC accumulation in the central area
of the synapse, the cSMAC. The question then was if other molecules exhibit the same behaviour.
It has been suggested that LFA-1-ICAM-1 complexes can also be affected by the centripetal flow
of F-actin arcs [116]. A centripetal force on LFA-1-ICAM-1 was added then to the in silico model,
similar to TCR-pMHC complexes and the impact on IS formation was analysed and compared
with the case were only TCR-pMHC complexes bind to actin (Figures 3.3).
The localization of TCR-pMHC microclusters and the “bull’s eye” were mainly unaffected,
though the microclusters moved slower to the cSMAC due to higher density of LFA-1 around
the cSMAC. In contrast to Figure 3.3a, the model showed that the centripetal flow of LFA-1-
ICAM-1 complexes leads to the formation of a LFA-1 density gradient in the pSMAC (Figure
3.3b, c): In comparison, without attachment to F-actin, LFA-1-ICAM-1 complexes were uniformly
spread throughout the pSMAC (red solid line). Actin binding led to a higher concentration of
LFA-1-ICAM-1 around the cSMAC that reduced as the distance from the center increased (red
dashed line). This quantitatively illustrates the gradient observed in Figure 3.3b. Interestingly,
the predicted LFA-1 gradient was also found in experiments [116, 196]. According to the model,
the interplay of actin-mediated forces together with diffusion are responsible for the formation of
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Figure 3.1: Formation of the immunological synapse. (a) TCR-pMHC and LFA-1-ICAM-1 com-
plexes are only diffusing. (b) Addition of SBS between TCR-pMHC and LFA-1-ICAM-1 complexes.
(c) Addition of TCR-pMHC coupling to actin, CTM = 1.0, and consequently centripetal force on
TCR-pMHC. (d) Radial density profile of complexes along the distance from the center at 600
second, for (a) solid , (b) dashed and (c) dotted lines. Error bars represent the SD of n = 10
simulations. TCR-pMHC: green, LFA-1-ICAM-1: red.
an LFA-1 gradient in the IS.
I further analysed the RDFs between TCR-pMHC complexes and compared between presence
and absence of LFA-1 gradient (Figure 3.4). There are no significant differences in the localization
of TCR-pMHC in the two cases studied here. In the case of LFA-1 coupling to the F-actin flow, the
TCR-pMHC microclusters at 60, 300, as well as at 600 seconds, seemed more densely packed than
in the case of absence of LFA-1 interaction with actin (Figure 3.4a). This is observed by the higher
values obtained for the first case, as a result of the combined exclusion of TCR-pMHC due to SBS
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Figure 3.2: Radial distribution functions of Figure 3.1c at 60 (solid line), 300 (dashed line) and
600 seconds (dotted line), between (a) pairs of TCR-pMHC and (b) between TCR-pMHC and
LFA-1-ICAM-1 complexes.
and LFA-1 centripetal flow. Nonetheless, these negligible differences showed that TCR-pMHC flow
and accumulation in the cSMAC are not significantly affected by the emerging LFA-1 gradient.
On the contrary to TCR-pMHC, LFA-1-ICAM-1 localization with respect to TCR-pMHC com-
plexes seemed to be highly affected. At the first moments of the IS formation (60 seconds) there
were no significant differences between presence or absence of LFA-1-ICAM-1 coupling to actin (Fig-
ure 3.4b, solid lines). At 300 and 600 seconds though, LFA-1-ICAM-1 appeared at higher densities
and closer to the TCR-pMHC complexes, when they were coupled to actin (Figure 3.4b, dashed
and dotted lines). Eventually, the halo between central and peripheral SMACs persisted [195], but
the density of LFA-1 in the inner pSMAC was a lot higher than before (Figure 3.3a, b).
The power of the model is that physiological parameters can be monitored or altered to make
predictions. One such prediction is the importance of physiologically correct association and dis-
sociation rates, as depicted in Figure 3.5, in absence or presence of LFA-1 gradient. The reference
values are kon,TM = 2 ∗ 104 M−1s−1, kon,LI = 3 ∗ 105 M−1s−1, koff,TM = 0.1 s−1, Koff,LI = 0.03 s−1
and will be used throughout this study. Decreasing the TCR-pMHC on-rates resulted in smaller
cSMAC due to the difficulty in forming complexes, while increasing them, resulted in a bigger
and denser cSMAC than before (Figure 3.5a, b (a-b)). Similarly, by decreasing the off-rates, the
cSMAC becomes more dense, as it is more difficult for the complexes to return to the free molecule
state (Figure 3.5a, b (c)). Accordingly, increasing the off-rate, led to a less dense cSMAC (Figure
3.5a, b (d)). Altering the association and dissociation rates of LFA-1-ICAM-1 complexes had sim-
ilar effects on the pSMAC population. Reduction of the on-rates led to a less dense pSMAC, while
increasing it, resulted in a higher density of complexes in the pSMAC (Figure 3.5a, b (e-f)). Fi-
nally, lower off-rates led to a denser pSMAC, while faster dissociation of LFA-1-ICAM-1 complexes
resulted in a sparse pSMAC (Figure 3.5a, b (g-h)).
The model can also be extended to perform selective inhibition of different processes. Arrest
of the coupling to F-actin experimentally would mean that no complex can be transported by
interacting with it. However, I used the model so far to investigate the synapse when neither
TCR-pMHC nor LFA-1-ICAM-1 couple to the F-actin centripetal flow (Figure 3.1b), or when only
TCR-pMHC interact with it (Figure 3.1b) or finally, both TCR-pMHC and LFA-1-ICAM-1 are
centrally transported (Figure 3.3b). But what would happen if the binding of TCR-pMHC to F-
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actin was arrested while LFA-1-ICAM-1 could still bind to it (Figure 3.6)? SBS once again resulted
in the emergence of a multifocal pattern, where TCR-pMHC microclusters failed to merge into the
cSMAC, same as in Figure 3.1b. The centripetal transport of the LFA-1-ICAM-1 complexes led
to their accumulation in the center of the contact region, and at the same time, TCR-pMHC
microclusters were passively excluded toward the periphery (t = 5 minutes), where they ended up
in a ring structure at the distal SMAC (dSMAC) (t = 10 minutes). Intuitively, from that in silico
experiment, I concluded that for proper IS formation, the centripetal actin-driven force on LFA-1
must be lower than on TCR, and that the emerging radial LFA-1 gradient affects the localization
of other molecules of the IS [180].
In conclusion, the model so far was able to recapitulate the dynamics of IS formation, with
physiological parameters, as described experimentally [79, 108]. TCR-pMHC microclusters ap-
peared from the first minutes of T cell-SLB interaction, which merged into bigger clusters before
eventually accumulating in the center of the contact region, forming the cSMAC. Interstingly, the
emergence of the pSMAC LFA-1-ICAM-1 gradient toward the cSMAC was also observed in ac-
cordance with experimental findings [116, 196]. The model explained so far is the basis of further
investigations performed for the localization mechanisms and different spatial patterns appearing
when different molecules are taken into consideration. The first thing to discuss will be the effect
of the LFA-1 gradient on other molecules present during T cell activation.






































































LFA-1-ICAM-1 coupling to actin (b)
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Figure 3.3: LFA-1 coupling to F-actin induces a gradient of LFA-1-ICAM-1 complexes. (a), (b)
IS formation at 60, 120, 300 and 600 seconds (a) with TCR-pMHC coupling to F-actin, CTM = 1.0
(same with Figure 3.1c) and (b) with TCR-pMHC and LFA-1-ICAM-1 attachment to F-actin,
CTM = 1.0 and CLI = 0.05, respectively. TCR-pMHC: green, LFA-1-ICAM-1: red. (c) Radial
density profile of complexes along the distance from the center at 600 second, without (solid) or
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TCR & LFA-1-F-actin coupling
Figure 3.4: Radial distribution functions of Figure 3.3 at 60 (solid line), 300 (dashed line) and
600 seconds (dotted line), between (a) pairs of TCR-pMHC and (b) between TCR-pMHC and
LFA-1-ICAM-1 complexes. Absence of LFA-1-ICAM-1 coupling to actin: black lines. Presence of
LFA-1-ICAM-1 coupling to actin: red lines.
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Figure 3.5: Effect of altering the association, kon, and dissociation, koff , rates for TCR-pMHC
and LFA-1-ICAM-1 complexes, with (a) absence, CLI = 0.00 or (b) presence of LFA-1 coupling to
F-actin, CLI = 0.05. Changes made to the basic parameters, kon,TM = 2 ∗ 104 M−1s−1, kon,LI =
3∗105 M−1s−1, koff,TM = 0.1 s−1, koff,LI = 0.03 s−1, are depicted: (a) kon,TM = 2∗103 M−1s−1, (b)
kon,TM = 2 ∗ 105 M−1s−1, (c) koff,TM = 0.01 s−1, (d) koff,TM = 1.0 s−1, (e) kon,LI = 3 ∗ 103 M−1s−1,
(f) kon,LI = 3 ∗ 107 M−1s−1, (g) koff,LI = 0.003 s−1, (h) koff,LI = 3.0 s−1. TCR-pMHC: green,
LFA-1-ICAM-1: red.
TCR-pMHC LFA-1-ICAM-1
Figure 3.6: Blocking only TCR-pMHC centripetal motion and not LFA-1-ICAM-1 when the SBS
is taken into account. As LFA-1-ICAM-1 accumulate in the central region due to F-actin coupling,
TCR-pMHC are pushed to the outer part of the contact region, and eventually a ring of TCR-
pMHC appears in the dSMAC. (a)-(d) 60, 120, 300 and 600 seconds. TCR-pMHC: green, LFA-1-
ICAM-1: red.
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3.4 The LFA-1 gradient relocates unbound molecules
In order to investigate the effect of the LFA-1 gradient on other molecules and complexes taking
part in IS formation, extra agents will be introduced into model. What kind of agents should they
be? Where to start from? First of all, I looked for experimental data where the effect of the LFA-1
gradient is discussed. One such example investigates the localization of the costimulatory molecule
CD28 [196]. Luckily, in this article, the localization of both free and complexed CD28 molecules
is studied. In the next chapter, I will focus on the localization mechanisms of CD28 complexes,
but for now, the available data can be used to investigate how freely diffusing molecules move
within the forming synapse. The model was updated and CD28 molecules were introduced in the
T cell lattice. There were no interactions between the present TCR-pMHC and LFA-1-ICAM-1
complexes and free CD28 included, since the small free molecules should be able to move freely in
the contact interface. Initially, no ligand was introduced in the SLB, in order to investigate the
effect of the LFA-1 gradient on freely diffusing molecules. Experimentally, absence of ligand led
to a uniform distribution of CD28 molecules throughout the IS, with a higher accumulation in the
dSMAC region [196].
The model, in contrast to experiments, allows us to alter the strength with which LFA-1 couples
to actin, CLI. In the absence of LFA-1 coupling to actin, CLI = 0.00, free CD28 molecules were
uniformly spread in the contact region (Figure 3.7a (left)), which is in qualitative disagreement with
the experimental result. In contrast, LFA-1 coupling to actin, CLI = 0.05 − 0.10, split free CD28
into two populations, one into the cSMAC and another into the dSMAC (Figures 3.7a (middle,
right)), in agreement with experiments. Stronger coupling of LFA-1 to actin excluded more CD28
to the dSMAC, but still a substantial amount remained dispersed throughout the contact region
(Figure 3.7b) [180].
This result does not only apply to CD28, but to any small free molecule in the IS, which does
not interact with the surrounding complexes. The modeling results reveal that the predicted LFA-1
gradient, induced by its coupling to the centripetal flow of actin, is a mechanism with the potential
to divide free molecules in the IS into two populations, relocating them to the cSMAC and the
dSMAC. The question raising is if the localization of molecules longer than CD28, will be affected
in a different way. The characteristic example of CD45 molecules, which have the same size as an
LFA-1-ICAM-1 complex, ' 45 nm, and therefore are considered very long, will be discussed in the
following section.
3.5 CD45 localization is also affected by the LFA-1 gradient
Similar to free CD28 molecules, I considered the transmembrane protein phosphatase CD45. No
ligand has been described so far for CD45, but its presence in the synapse is considered very
important, since it affects TCR signaling [185–190]. Interestingly, CD45 is highly excluded from
the TCR regions. Davis and van der Merwe proposed the kinetic segregation model (KSM) [99],
which suggested that the T cell receptor can get activated due to the exclusion of phosphatases






















TCR-pMHC LFA-1-ICAM-1 free CD28
Figure 3.7: Impact of the LFA-1 gradient on free CD28 molecules, in the absence of the CD80
ligand. (a) Altering LFA-1 actin coupling strength, (left) CLI = 0.00, (middle) CLI = 0.05 and
(right) CLI = 0.10 at 600 seconds. (b) Radial density profile of free CD28 molecules along the
distance from the center at 600 seconds. Error bars represent the SD of n = 10 simulations.
TCR-pMHC: green, LFA-1-ICAM-1: red, CD28: yellow.
like CD45, further supported by the observation of higher calcium flux when CD45 molecules
are excluded from the centripetally travelling TCR-pMHC microclusters [92, 197]. Hence, the
mechanisms of the particular localization and dynamics of CD45 are relevant to understand the
regulation of TCR signaling in the synapse [108,194].
The agent-based model was complemented with freely diffusing CD45 molecules, without any
interactions with TCR-pMHC and LFA-1-ICAM-1 taking place. In that case, CD45 was observed
to localize uniformly spread throughout the contact interface (Figure 3.8 (first column)). As
before, the emergence of the LFA-1 gradient, excluded more and more CD45 molecules towards
the dSMAC as the centripetal force, CLI, became larger. Despite the exclusion, the thick CD45
ring in the dSMAC was not reproduced, with a substantial amount remaining trapped in the
central-peripheral SMAC border [185,197]. The proposed KSM as well as the size of the diffusing
CD45 molecules, ≈ 45 nm, pointed to the introduction of additional mechanisms [99,198].
The idea was that since CD45 molecules do not have known ligands, they could possibly bend
and fit into close contact regions, such as the TCR-pMHC microclusters. KSM suggested that
conformational changes on the intracellular tales of TCR and CD45 molecules during antigen
recognition might be responsible for the exclusion of CD45. In order to keep the model as simple as
possible, I avoided to introduce complex mechanisms, such as conformational changes or membrane
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bending. Instead, the exclusion of CD45 from the TCR microclusters was modelled as a repulsive
force, representing the effect of KSM. This force is similar to the repulsive forces due to size-based
segregation (SBS). This repulsive force was defined within a radius RCD45TCR, and was weighted by
WCD45TCR. The range of CD45-TCR interaction was set to be at maximum equal to the range of
TCR-pMHC and LFA-1-ICAM-1 interaction, since the size of LFA-1-ICAM-1 complexes are similar
to that of CD45. Therefore, I investigated repulsion radii of RCD45TCR = 0.14− 0.42µm, and the
forces were weighted with WCD45TCR = −1.0. As the interaction range increased, CD45 were
excluded from the TCR regions, and colocalized with LFA-1 in the pSMAC. The additional LFA-1
pSMAC gradient further excluded CD45 toward the dSMAC but still a substantial population
remained in the pMSAC region (Figures 3.8a, b). One could argue that the amount of exclusion
achieved only by the combined repulsion from TCR-pMHC and the LFA-1-ICAM-1 gradient on
CD45, is enough to reproduce the experimental observations, as seen in Figure 3.8a for RCD45TCR ≥
0.28µm and LFA-1-F-actin interaction strength of CLI ≥ 0.05 [185,197].
However, I still wanted to investigate if an additional repulsion from LFA-1-ICAM-1 to CD45
would affect the observed IS pattern. Similar to the interaction with TCR-pMHC, the repulsion
between LFA-1 and CD45 was defined in a range RCD45LFA = 0.00− 0.28µm, and weighted with
WCD45LFA = −1.0. The LFA-1 centripetal force was set equal to CLI = 0.05, as in most of the
cases presented. As seen in Figures 3.9a (bottom row, second column) & b (green dotted line), a
very weak repulsion from LFA-1, in the range of RCD45LFA = 0.14µm, managed to exclude almost
100% of CD45, which formed a dense dMSAC ring structure, provided there was strong exclusion
from TCR. Interestingly, stronger repulsion between CD45 and LFA-1-ICAM-1, instead of leading
to complete exclusion of CD45, blocked its outward movement and resulted in clusters of CD45
appearing around the cSMAC or even spread in the pSMAC region (Figure 3.9a (bottom right
corner)).
These results together suggest that the repulsive interaction between CD45 and TCR-pMHC
due to KSM or simply due to size exclusion by SBS, can recapitulate the experimentally observed
CD45 dSMAC ring structure. Interestingly, CD45 localization is also affected by interactions with
LFA-1-ICAM-1. Weak repulsion can additionally help CD45 reach the dSMAC, whereas stronger
repulsion can block its outward flow, suggesting that if this interaction is present in reality, it has
to be a weak one.
3.6 Conclusions
In this chapter, I showed that the agent-based model was able to reproduce the observed character-
istic IS pattern [68, 79], with very simple mechanisms. SBS was able to segregate long from short
complexes, while centrally directed transport of complexes representing coupling to the F-actin arc
flow, resulted in the accumulation of TCR-pMHC complexes in the central area of the cell-cell con-
tact interface. The model predicted the emergence of an LFA-1-ICAM-1 gradient in the pSMAC
region toward the cSMAC, provided the interaction of these complexes with actin centripetal flow.
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RCD45TCR=0.00 m RCD45TCR=0.14 m RCD45TCR=0.21 m RCD45TCR=0.28 m RCD45TCR=0.35 m RCD45TCR=0.42 m
Figure 3.8: CD45 localization during interaction with TCR-pMHC complexes at 10 minutes of
IS formation. (a) Different centripetal force of LFA-1-ICAM-1 complexes together with different
strengths of repulsion, RCD45TCR between CD45 and TCR-pMHC. (b) Amount of CD45 in the
central, peripheral and distal SMAC. TCR-pMHC: green, LFA-1-ICAM-1: red, CD45: white.
The effect of the LFA-1 gradient was studied in the case of freely diffusing molecules, without
ligand. The emergence of the gradient resulted in the separation of these molecules into distinct
populations, one in the cSMAC region and another in the outer pSMAC and dSMAC region.
In the following chapter, I will investigate the effect of the LFA-1-ICAM-1 gradient on additional
complexes forming by the introduction of new molecules to the model. Further localization mech-
anisms for the newly introduced complexes will be studied and discussed, based on experimental
observations.
3.6. CONCLUSIONS 57

























































TCR-pMHC LFA-1-ICAM-1 free CD45
Figure 3.9: Impact of an additional LFA-1-ICAM-1 repulsion toward CD45. (a) IS pattern at 10
minutes, in presence of TCR-pMHC and LFA-1-ICAM-1 repulsive force on CD45. (b) Amount
of CD45 in the central, peripheral and distal SMAC. TCR-pMHC: green, LFA-1-ICAM-1: red,
CD28: white.
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Chapter 4
F-Actin-Driven CD28-CD80
Localization in the Immune
Synapse
4.1 Introduction
T cells require two signals in order to get activated. The first signal is antigen specific, and is
provided by the TCR-pMHC engagement. The second signal comes from so called costimulatory
molecules. This signal is not antigen-specific and requires the binding of surface molecules on the
T cell surface to molecules present on the APC surface. There are many examples of costimulatory
molecules, such as CD28, CD2, ICOS and others. The signals received from such costimulatory
molecules are essential for T cell proliferation, differentiation and survival.
In this chapter, I will talk about CD28. As already mentioned in the previous chapter, freely
diffusing CD28 molecules are relocated by the emergence of the LFA-1 gradient in the pSMAC.
Here, I will investigate the behaviour of CD28 in presence of one of its ligands and explore their
localization mechanisms. CD28 carries a significant role for regulatory and follicular helper T cell
differentiation [199,200]. Binding of CD28 to one of its major ligands, CD80 (B7-1) and CD86 (B7-
2), supports TCR signaling [201,202], while a lack of CD28 costimulation leads to an apathetic state
of the T cell, known as anergy, where killing or boosting of other cells is impaired [201,203,204].
CD28 has been shown to preferentially locate in the cSMAC [196, 205]. This particular local-
ization was attributed to the ligation with CD86 [204], or CD80 [206]. A ring of CD28 around the
cSMAC has been described [206], and was further confirmed by the colocalization of CD28 and
protein kinase Cθ (PKCθ) that also forms a ring around the cSMAC [196, 207, 208]. The reasons
for this characteristic pattern are still poorly understood. The cytoplasmic domain of CD80 was
shown to segregate CD28 from TCR complexes whereas the tailless form of CD80 allows colocal-
ization with TCR [206]. CD80 is not sufficient for a proper CD28 localization, since a mutation in
59
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the cytosolic tail of CD28 disrupts the ring-like pattern [207]. There is also evidence that CD28
binds to F-actin, since it is observed to recruit Filamin-A (FLNa), an actin binding protein, upon
ligation [209, 210]. Cytoskeleton-driven motion is further supported by a linear motion of CD28
complexes toward the cSMAC [183], raising the question whether actin-driven forces could explain
the localization of CD28.
The majority of experimental data available use only CD80 ligands instead of CD86 [196]. The
model was therefore extended to include CD80 ligand on the SLB lattice, in order to compare the
in silico results with experimental work [196]. The size of CD28-CD80 and TCR-pMHC complexes
is very similar, ' 11 nm, such that I assume no SBS between them unless stated otherwise, and
the same SBS to LFA-1-ICAM-1 as for TCR-pMHC. Physiological parameters for the association
and dissociation rates were taken from literature, kd = 4µM, with koff ≥ 1.6 s−1 and kon ≥
4× 105 M−1s−1 [211,212] (see Table 2.1).
4.2 CD28 complexes behave as passive followers of TCR-
pMHC movement
The in silico experiments began with the same setting as in Figure 3.3b. TCR-pMHC segregate
from LFA-1-ICAM-1 complexes due to SBS and further centripetal force on TCR-pMHC and LFA-
1-ICAM-1 complexes leads to the accumulation of TCR-pMHC in the cSMAC and the emergence
of the LFA-1-ICAM-1 gradient in the pSMAC region toward the SMAC. Initially, only SBS be-
tween CD28-CD80 and LFA-1-ICAM-1 complexes was introduced into the model. In this way,
CD28-CD80 complexes were sterically excluded and pushed into the TCR-pMHC microclusters.
The majority of CD28-CD80 did not reach the SMAC as is experimentally observed [196], due to
the LFA-1 gradient repelling them from the inner pSMAC region (Figure 4.1a, c (dashed line)).
However, a substantial amount passively followed the centripetal movement of TCR-pMHC mi-
croclusters, a behavior not appreciated before, resulting in a small CD28-CD80 ring around the
cSMAC (Figures 4.1a, 4.2 (dashed line)).
This behavior occurred due to the SBS between CD28-CD80 and LFA-1-ICAM-1 in combination
with the TCR-pMHC centripetal flow, which allowed CD28 complexes to follow low tension paths
toward the center. The CD28 ring generated by passively following TCR-pMHC movementin silico
was too weak to explain the experimentally observed CD28 ring around the cSMAC [196]. Hence,
there are mechanisms that had to be included in order to in silico recapitulate the appropriate
CD28-CD80 annular localization.
4.3 Actin-dependent localization of CD28
Several experimental studies suggested a potential actin-driven motion of CD28 complexes [183,209,
210]. The effect of this interaction was analysed in the model (Figure 4.1b). SBS between CD28-
CD80 and LFA-1-ICAM-1 as before, together with a CD28-CD80 actin coupling were sufficient to
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colocalize CD28-CD80 complexes with TCR-pMHC microclusters and to form a CD28 ring around
the cSMAC (Figures 4.1b, c (solid line), 4.2 (solid line)) as in experiment [196].
CD28 coupling to actin did not change colocalization of TCR-pMHC and CD28-CD80 at the
early times of IS formation (Figure 4.2a, 60 seconds). However, after 120 and 300 seconds, colo-
calization of CD28 and TCR complexes was decreased without actin coupling (Figure 4.2a). With
actin coupling, it remained stable and increased after 600 seconds when the cSMAC formed. In in
silico microclusters, CD28 hardly colocalize with TCRs at a distance of less than 210 nm (Figure
4.2b). This reflects the fact that TCRs move faster to the center than CD28. However, actin
coupling resulted in a higher colocalization of CD28 and TCR in the ring around the cSMAC.




























































Figure 4.1: Effect of CD28-CD80 actin coupling on the dynamics of the IS. IS formation at 60,
120, 300 and 600 seconds, (a) with absence of CD28-CD80 coupling to actin, CCC = 0.00 and (b)
with presence of CD28-CD80 coupling to actin, CCC = 0.20, in the presence of a LFA-1 gradient.
(c) Radial density profile of complexes along the distance from the center at 600 seconds, with or
without CD28 coupling to actin. Error bars represent the SD of n = 10 simulations. TCR-pMHC:
green, LFA-1-ICAM-1: red, CD28-CD80: yellow.
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Figure 4.2: CD28-actin coupling impacts on colocalization of CD28-CD80 and TCR-pMHC. (a)
Radial distribution function of Figure 4.1, at 60, 120, 300, and 600 seconds of IS formation with
(CCC = 0.20) or without (CCC = 0.00) CD28 coupling to actin. (b) Short distance colocalization
at less than 210 nm (blue) of CD28-CD80 and TCR-pMHC, with (CCC = 0.20) or without (CCC =
0.00) CD28 coupling to actin. TCR-pMHC: green, LFA-1-ICAM-1: red, CD28-CD80: yellow,
Colocalization: Cyan.
4.4 Model calibration
The use of SLB systems allows biologists to control and quantify the ligand concentrations, which
would be almost impossible in the 3D T cell-APC system. For the in silico CD28 localization study,
I used a variety of CD80 concentrations, ranging between 60−120% of the amount of floating ICAM-
1 on the SLB [196]. Similarly to the experiments, I investigated these concentrations of CD80 ligand
on the SLB lattice (Figure 4.3). The patterns were recapitulated within the experimental range,
and therefore I decided to perform all the in silico experiments with CD80 at 60% of ICAM-1.
Similar to the case of TCR-pMHC and LFA-1-ICAM-1 synapse formation, I investigated
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possible changes in the emerging patterns, by altering the association and dissociation rates of
CD28-CD80 complexes. The dissociation constant for CD28-CD80 complexes is kd = 4µM, with
koff ≥ 1.6 s−1 and kon ≥ 4×105 M−1s−1 (Figure 4.4e) [211]. As seen in Figure 4.4, only the amount
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Figure 4.3: Model calibration for the amount of CD80 molecules. Variation between 60− 120% of
ICAM-1 amount, for constant CD28-CD80 coupling to actin strength, CCC = 0.20. (a) Absence
of LFA-1-ICAM-1 coupling to F-actin, CLI = 0.00. (b) Presence of LFA-1-ICAM-1 coupling to
F-actin, CLI = 0.05. (c) CD28-CD80 localization in the IS, in absence (left graph) or presence
(right graph) of LFA-1 coupling to F-actin. TCR-pMHC: green, LFA-1-ICAM-1: red, CD28-CD80:
yellow.
4.5 Model Robustness
To investigate the robustness of the results presented, additional in silico experiments for molecular
crowding were performed. The total density of the molecules in Figure 4.1b was gradually increased
from 30% to 60% (Figure 4.5a). As expected, this increased the sizes of the cSMAC and the
CD28 ring (Figure 4.5a), and, consequently, pushed the LFA-1 pSMAC further away from the IS
center. Despite of size changes, the required mechanisms for the formation of the ring-like structure
remained the same.
















Figure 4.4: Model calibration for the On and Off rates of CD28-CD80. Keeping kon constant
and increasing koff (first row), having kd constant and increasing both kon and koff (second row)
and finally, koff constant while increasing kon (third row). The values shown in (e), kon = 4 ×
105 M−1s−1, koff = 1.6 s−1 with kd = 4µM, are the ones used throughout this article. When
a value is considered constant, it is taken from (e). (a) koff = 6 s
−1, (b) koff = 12 s−1, (c)
koff = 24 s
−1, (d) kon = 15 ∗ 105 M−1s−1, koff = 6 s−1, (f) kon = 30 ∗ 105 M−1s−1, koff = 12 s−1, (g)
kon = 15 ∗ 105 M−1s−1, (h) kon = 30 ∗ 105 M−1s−1 and (i) kon = 60 ∗ 105 M−1s−1. TCR-pMHC:
green, LFA-1-ICAM-1: red, CD28-CD80: yellow.
Starting from Figure 4.1b, we introduced different densities of an extra population of arbitrary
molecules (AM) on the T cell lattice without ligands on the SLB. Similar to Figure 3.7, AM are
affected by the LFA-1 gradient in the pSMAC and are excluded to the outer region of the IS.
With increasing AM density, and based on the same mechanisms for pattern formation, CD28
localization was affected but not to a degree that changed its annular accumulation around the
cSMAC (Figure 4.5b, d (left graph)).
In order to exclude that the lattice resolution of α = 70 nm would generate artefacts, we
replicated the critical simulations with different lattice resolutions, α = 100, 50, 35, 17 nm (Figure
4.5c, d (right graph)). The localization of all the complexes, TCR-pMHC, LFA-1-ICAM-1 and
CD28-CD80 was not affected as shown in Figure 4.5d (right graph), and can be appreciated from
the IS formation snapshots in Figure 4.5c.
Additionally, a swapping algorithm was implemented, which allowed agents moving by active
forces, such as repulsion and centrally-directed force, to exchange positions when the two agents
wanted to move to the other’s position [180,182]. This generated a more realistic fluidity similar to
a lattice gas model. Similarly to the previous robust experiments, all the mechanisms and patterns
remained in accordance to the reference resolution of α = 70 nm (Figure 4.6).
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All together, the results show that CD28 coupling to the centripetal actin flow is sufficient for
the formation of the ring-like structure and that SBS and passive following alone are not able to
generate this pattern.

























































































TCR-pMHC LFA-1-ICAM-1 CD28-CD80 Arbitrary molecules (AM)
Figure 4.5: Robustness of the results to molecular crowding and resolution changes. (a) Increase
of the total density on the lattices, Total density = 30%, 45%, 60%. (b) Introduction of an
arbitrary molecule (AM) without ligand that only diffuses on the T cell lattice. Titration of the
amount of AM from 6 to 48% density on the T cell lattice, and total density ranging from 36% to
78%. (c) Altering of the resolution of the simulation from α = 70 nm to α = 100, 50, 35, 17 nm,
respectively. CTM = 1.00, CLI = 0.05 and CCC = 0.20. (d) Complex localization in the different in
silico simulations of (b) (left graph) and (c) (right graph). TCR-pMHC: green, LFA-1-ICAM-1:
red, CD28-CD80: yellow, AM: cyan.
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Figure 4.6: Robustness of the results to the exchange algorithm and resolution changes. (a)
Altering of the resolution of the simulation together with the exchange algorithm from α = 70 nm
to α = 100, 50, 35 nm, respectively. CTM = 1.00, CLI = 0.05, CCC = 0.20 and CCC = 0.00. (b)
Complex localization of the different resolutions and different CD28 actin coupling, CCC = 0.00
and CCC = 0.20. TCR-pMHC: green, LFA-1-ICAM-1: red, CD28-CD80: yellow.
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4.6 Model predictions on CD28-CD80 localization
The strength of the model becomes obvious when it comes to predictions. In Section 3.3, we
showed that we can selectively inhibit molecules from F-actin interactions, and predict the cell-cell
IS pattern. We showed that LFA-1-ICAM-1 coupling to F-actin in the absence of TCR-pMHC
centripetal flow leads to the exclusion of the second to the outer region of the IS (Figure 3.6).
Similar predictions were made with CD28, where coupling to F-actin led to the characteristic
annular localization, while arrest of F-actin coupling resulted in the staggering behaviour of passive
following of the TCR-pMHC molucules (Figure 4.1). What else can the model predict?
4.6.1 Geometrical repatterning of the SLB can distinguish between pres-
ence or absence of CD28-CD80 F-actin coupling
A characteristic example of experiment-model-experimental interaction came from some of the
first models presented [71, 100, 174]. Mossman et al. showed that TCR signaling was affected by
introducing chromium barriers on the SLB that blocked diffusion [71]. Later, Figge and Meyer-
Hermann tried to distinguish between TCR centripetal flow versus long range attraction between
TCR-pMHC complexes using barriers on the in silico SLB [174], suggesting that further experi-
ments where needed in order to distinguish between the different forces. These experiments where
performed by DeMonde et al., and showed that TCR-pMHC bind to F-actin and are centripetally
transported [100]. Therefore, we used the same approach, trying to perform in silico experiments,
which are easy to be experimentally investigated.
In order to find a criterion that allows to distinguish pure passive following from CD28-CD80
coupling to actin, we investigated how barriers in several shapes that block the diffusion of molecules
and complexes on the SLB would influence IS formation (Figure 4.7) [71, 100]. Colocalization of
CD28 and TCR was stronger when CD28 coupling to actin was allowed. Without actin coupling,
most of CD28 was located in the dSMAC (Figure 4.7a). In the annular and square setting, a
structural difference is found: With passive following alone, CD28 accumulates on both sides of
the barriers (Figure 4.7a Annular, Square), which are low tension areas due to the accumulation
of TCR complexes. Still, a substantial amount manages to reach the cSMAC but less compared to
when F-actin coupling is considered. In this case, CD28 accumulates on the outside of the barriers
and in the center of the IS (Figure 4.7b Annular, Square) [180]. This is a result of the continuous
centripetal flow which is either interrupted by the barrier or guides CD28 into the cSMAC area.
Thus, an experiment using such constraints in the SLB would reveal whether CD28 is coupled to
actin or not [71,100].
4.6.2 Existence of an optimal F-actin coupling strength
Next, we asked to which extent actin coupling controls CD28-CD80 localization and varied the
coupling strength from complete absence, CCC = 0.00, to strength same as the one on TCR-
pMHC complexes, CCC = 1.0 (Figure 4.8). Both, TCR and LFA-1 coupling were kept as in Figure
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Figure 4.7: Effect of barriers added to the SLB that block the diffusion of CD28-CD80 complexes.
(a) Absence of CD28-CD80 coupling to actin, CCC = 0.00. (b) Presence of CD28-CD80 coupling
to actin, CCC = 0.20. TCR-pMHC: green, LFA-1-ICAM-1: red, CD28-CD80: yellow.
4.1b. The amount of CD28 in the cSMAC and in the surrounding ring increased with increasing
coupling strength (Figure 4.8b), while the dSMAC population was decreased. The time of pattern
formation and the coupling strength were not clearly correlated and for weak actin coupling, the
ring pattern never developed, even at later simulation times. Our analysis suggested that the
ring-like structure is a result of the complex combination of (i) SBS between CD28 and LFA-
1 complexes, (ii) CD28 passively following TCRs, and (iii) the centripetal force on CD28 due to
actin coupling. We identified an optimal coupling strength of CD28 to actin, which best reproduces
the experimentally observed pattern [196]. Weaker actin coupling led to the separation of CD28
into two distinct populations in the cSMAC and the dSMAC (Figure 4.8a (CCC = 0.00 − 0.10)),
in contrast to [196]. Stronger actin coupling led to an unrealistically high colocalization of CD28
and TCR complexes in the cSMAC and the microclusters (Figure 4.8a (CCC = 1.00)), and to the
absence of the ring-like pattern of CD28.
This shows that the relative localization of CD28-CD80 in the cSMAC versus dSMAC can
be tightly regulated by actin forces, and that the experimentally observed CD28 ring suggests
a substantial, actin-driven motion of CD28. Note that the existence of an optimal CD28 cou-
pling strength to actin does not rely on the LFA-1 gradient in the pSMAC and is also evident in
simulations where we inhibited the LFA-1-ICAM-1 coupling to actin (Figure 4.9).
4.6.3 Could a CD28-TCR interaction alter F-actin coupling strength?
Despite of the similar sizes between TCR-pMHC and CD28-CD80 complexes, there are experi-
mental observations showing that even a tiny difference in the range of 2 − 3 nm, could induce
steric exclusion. Therefore, SBS between CD28-CD80 and TCR-pMHC complexes was introduced
to the model. Then we hypothesized that if CD28-CD80 coupling to actin is stronger than the
optimal value obtained in Figure 4.8, a repulsive force from TCR-pMHC should still lead to the








% CD28-CD80 in SMACs
TCR-pMHC LFA-1-ICAM-1 CD28-CD80
Figure 4.8: Variation of the strength of CD28 coupling to actin. (a) CCC =
0.00, 0.05, 0.10, 0.20, 0.50 and 1.00 = CTM. TCR-pMHC: green, LFA-1-ICAM-1: red, CD28-
CD80: yellow. (b) Amount of CD28-CD80 complexes in the different regions of the IS, cSMAC,
ring around cSMAC and dSMAC. Error bars represent the SD of n = 10 simulations.
experimentally observed annular pattern.
Therefore, we performed in silico experiments in the limit of strong coupling of CD28 to actin
for the intermixed pattern observed in the cSMAC (Figure 4.8 (CCC ≥ 0.50)). SBS in different
radii, RSBS,CC−TM = 0.14−021µm, and strengths, WSBS,CC−TM ∈ (−1.0, −0.2), was then applied
between TCR-pMHC and CD28-CD80 complexes. Initially, the effect of SBS was investigated for
the case of optimal CD28-F-actin coupling strength (Figure 4.10). SBS was unable to affect the
ring structure in the IS with the optimal CD28 coupling to actin (Figure 4.10c). For higher CD28
F-actin coupling strengths, CCC ≥ 0.50, the intermixed cSMAC pattern could not be resolved.
SBS led to TCR clustering in, and even exclusion from the cSMAC (Figure 4.10b, c). Thus, the
model predicts that the optimal CD28-CD80 coupling to actin is weaker than for TCR-pMHC.
Furthermore, the actin force acts as the regulator of CD28-CD80 distal to central SMAC ratio
(Figure 4.8).
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Figure 4.9: Blocking of LFA-1 actin coupling. (a) Step-by-step IS formation at 1, 2, 5 and 10
minutes, respectively, with CD28-CD80 coupling to actin, CCC = 0.20. (b) CD28 binding to actin
with different strengths, CCC = 0.00, 0.10, 0.50, = 1.00 = CTM, respectively. TCR-pMHC: green,
LFA-1-ICAM-1: red, CD28-CD80: yellow. (c) Density of complexes as a function of the distance
from the center at 10 minutes. Error bars represent the SD of n = 10 simulations.
4.7 Conclusions
The working model was complemented with CD28 and CD80 molecules on the T cell and SLB
lattice respectively. The localization of CD28-CD80 complexes was achieved with a combination
of three mechanisms. First, SBS with LFA-1 leading to their segregation and the colocalization of
CD28 and TCR complexes in the microclusters at the initial stages of IS formation. Second, CD28-
CD80 pairs passively following the TCR-pMHC movement toward the cSMAC, a behaviour not
appreciated before, and third, CD28-CD80 actively moving toward the center due to interaction
with the F-actin network, modeled as a centrally directed force.
The robustness of the mechanisms was tested in different settings, such as increased concentra-
tion of all molecules in the IS region, introduction of freely diffusing molecules and, finally, different
resolutions of the lattices.
Finally, the predictive power of the model was then presented. In silico experiments with

































































Figure 4.10: SBS between TCR-pMHC and CD28-CD80. (a) CCC = 0.20, (b) CCC = 0.50 and
(c) CCC = 1.00, for different radii of interaction, R = 0.14− 0.21µm, as well as different strengths
of the repulsive forces, W = (−1.0, −0.2). CLI = 0.05. TCR-pMHC: green, LFA-1-ICAM-1: red,
CD28-CD80: yellow.
that we can distinguish between CD28 complexes coupling to actin or not, just by observing the
emerging IS patterns. Furthermore, the optimal CD28-actin interaction strength was studied,
which is impossible with currently published experimental techniques.
The importance of CD28-CD80 in T cell activation drove the presented study of the mechanisms
of their localization. The model not only managed to recapitulate the experimentally observed
patterns with simple mechanisms, but also shed light onto unknown behaviours of these molecules.
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In the following chapter, another costimulatory molecule, namely CD2, with a completely different
localization is discussed.
Chapter 5
CD2 corolla pattern formation
5.1 Introduction
As was discussed so far, TCR signaling needs the costimulatory support of other molecules, such
as CD2 [212–215] and the previously discussed CD28 [196, 199, 200]. These two costimulatory
molecules have very similar size, with CD2-CD58 being around ' 13 nm [214] while CD28-CD80
being around ' 11 nm, and therefore I would expect them to locate at the same regions of the IS,
around the cSMAC as I was discussing in the previous chapter. Interestingly though, they reside
in completely different regions of the IS, with CD2 forming a flower petal-like pattern in the distal
SMAC (dSMAC), called corolla pattern, according to unpublished data by [216].
CD2 interacts with CD58 in humans and CD48 in rodents. Early studies measured the affinity
between CD2 and its ligands in different species, and observed that the interacting molecules
affect the adhesion between the two interacting cells [212, 217–221]. CD2 is considered to be one
of the most important costimulatory molecules. CD2-CD58 complex formation supports T cell
polarization [222]: CD2 is redistributed in the uropod and its compartmentalization with the
TCR prearranges the cellular activation machinery in a kind of presynapse. Espagnolle et al [223]
found that CD2-CD58 augments and sustains antigen-induced Ca2+ increase in interacting cells,
and that impeding interactions between CD2 and CD58 leads to impaired recruitment of PLCγ1.
Interestingly, CD2 and TCR synergize in order to activate PLCγ1 [223]. Therefore, the unique
spatial corolla pattern of CD2 in the synapse seems very important for the regulation of TCR
signaling in space and consequently the function of T cells.
In this chapter I will try to shed light into the mechanisms leading to the staggering CD2
localization. I will further investigate how a synapse with both the costimulatory molecules would
develop based on experimental observations [216].
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5.2 CD2-CD58 passive followers and exclusion from the IS
In order to understand the mechanisms driving the spatial organization of CD2-CD58 in the IS,
the model was put into test one more time [180]. In this case, I took into account TCR, LFA-
1 and CD2 on the T cell and their respective ligands, pMHC, ICAM-1 and CD58 molecules on
the supported lipid bilayer (SLB) lattice, respectively. Steric exclusion between TCR-pMHC and
LFA-1-ICAM-1 complexes due to size-based segregation (SBS) as well as F-actin driven centripetal
transport of complexes - which leads to the accumulation of TCR-pMHC in the central area of the
IS [104,105,180], and also to the development of an LFA-1-ICAM-1 gradient toward the center of
the IS in the pSMAC - are considered the standard mechanisms [116,180].
Next, CD2 and CD58 molecules were introduced, on the T cell and SLB lattice, respectively.
CD2 and CD58 bind and unbind according to association and dissociation constants taken from
literature [212,217–221]. The size of a formed CD2-CD58 complex is around 13 nm [214,224], and
very similar to that of a TCR-pMHC complex. Therefore, the model was complemented with SBS
between CD2-CD58 and LFA-1-ICAM-1, but no interaction between CD2-CD58 and TCR-pMHC
was introduced.
The in silico experiments showed that CD2-CD58 and TCR-pMHC complexes initially colo-
calize in the microclusters (Figure 5.1). Interestingly, similar to what I observed for CD28 (Figure
4.1a), a small population of CD2-CD58 complexes passively followed the TCR-pMHC movement
toward the center of the IS (Figure 5.1a). This population is called passive followers. Further,
the emergence of the LFA-1-ICAM-1 gradient in the pSMAC, excluded the rest of the CD2-CD58
complexes to the outer region of the IS (dSMAC). In these in silico experiments, the separation of
CD2-CD58 complexes into two distinct populations was observed. The passive followers resided
in an annular structure around the cSMAC, while the excluded population formed a ring in the
dSMAC region.
From Figure 5.1b, it was obvious that the excluded CD2-CD58 population is larger than the
passive followers. Further, observation of the localization dynamics (Figure 5.1c) showed that
initially (1-2 minutes) CD2-CD58 are dispersed throughout the forming IS, whereas at the later
stages (10 minutes) of IS formation, CD2 is separated into two populations. The initial in silico
experiments though, could not reproduce the reported flower like corolla pattern [216]. Thus,
additional simulations were necessary in order to reproduce the observed pattern.
5.3 CD2 titration leads to a solid annular dSMAC
Experimental observations suggested that one factor behind the corolla pattern appearance could
be the expression level of CD2 on the T cell surface [216], since for example memory T cells appear
to express more CD2 than naive T cells [225]. As a result, I decided to perform in silico experiments
where I titrated the amount of CD2.
The question I then asked, was if the amount of CD2 in the IS region could lead to the
characteristic pattern, since there are observations that high expression of CD2 in T cells alters their
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Figure 5.1: CD2-CD58 is separated into two populations. (a) IS Formation dynamics between 1
and 10 minutes. (b) Radial density profiles of all the complexes (TCR-pMHC, LFA-1-ICAM-1,
CD2-CD58) along the distance from the center at 10 minutes. (c) Dynamics of the radial density
profiles of CD2-CD58 complexes along the distance from the center at 1, 2, 5 and 10 minutes.
TCR-pMHC: green, LFA-1-ICAM-1: red, CD2-CD58: magenta.
localization [216]. The amount of CD58 in the SLB lattice was adequate, 100 CD58 molecules/µm2,
so that it didn’t act as a limiting factor for CD2 binding. I then studied the localization of CD2-
CD58, starting with a population of as low as 1 and reaching up to 73 CD2 molecules/µm2, where
for the sake of simplicity only concentrations between 9 and 55 CD2 molecules/µm2 are shown.
As the initial CD2 population increased, the CD2-CD58 ring in the dSMAC became more
prominent (Figure 5.2a, b). Further, the increased CD2 amount led to increased population size
in the dSMAC (Figure 5.2b). Interestingly, as a result of steric exclusion between CD2-CD58 and
LFA-1-ICAM-1, the passive follower population in the ring around the cSMAC saturated at a
maximum capacity (Figure 5.2b). Once again though, no clustering in the dSMAC ring appeared.
The absence of the CD2-CD58 corolla pattern led to investigating additional mechanisms, which
could lead to the clustering of CD2 in the dSMAC.
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Figure 5.2: CD2 initial amount titration with constant CD58 amount. (a) Titration of the initial
CD2 amount. (b) Radial density profiles of CD2-CD58 complexes along the distance from the
center for different initial CD2 amounts. TCR-pMHC: green, LFA-1-ICAM-1: red, CD2-CD58:
magenta.
5.4 CD2-CD58 self attraction results in the corolla pattern
Despite the exclusion of the majority of CD2-CD58 from the IS, the corolla pattern failed to
form. In an attempt to achieve this characteristic pattern, an attractive interaction between CD2-
CD58 complexes was included in the model. This interaction has a strength WAtt, Self > 0 and
the complexes interact within a radius RAtt, Self . The radius defines the number of interacting
neighbors, here shown between 3 and 6 neighbors, RAtt, Self = 0.21− 0.42µm.
As the initial CD2 amount increased, together with increased radius of interaction, CD2-CD58
clustering appeared in the dSMAC, at least after considering more than four interacting neigh-
bors, RAtt, Self ≥ 0.28µm (Figure 5.3). This added mechanism resulted in the desired corolla pat-
tern [216]. The model not only reproduced the experimental results, but close observation of the
formation dynamics of Figure 5.5 showed the same behaviour of CD2-CD58 movement in the form-
ing IS. Initially, CD2-CD58 colocalized with TCR-pMHC in microclusters and moved inwards as
passive followers (Figure 5.1 & CD2localizationTitration, 1-2 minutes). Between 2 and 5 minutes,
they localized in the pSMAC while being excluded toward the dSMAC from the LFA-1-ICAM-1
gradient (Figure 5.1, 5.2 & 5.5). Finally, the CD2-CD58 clusters formed the corolla pattern, which
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remained stable after 10 minutes (Figure 5.5). Interestingly, examination between 10 and 30 min-
utes showed that CD2 clusters around the cSMAC eventually travelled toward the dSMAC corolla.
The clustering was lost at the highest CD2 concentrations, > 45 CD2 molecules/µm2, suggesting
that space is also an important factor.
I then went back to the experiments and investigated if indeed the concentration of CD2 on the
T cell and thereby within the contact interface affects the corolla pattern. Interestingly, for very
low amounts of expressed CD2, up to 4 CD2 molecules/µm2, the CD2-CD58 population is split
in ≈ 50% passive followers and ≈ 50% excluded into the dSMAC (Figure 5.4). At concentration
greater than 7 CD2 molecules/µm2, I observed a clear cut change in the localization of CD2-CD58
complexes. Around 90% of all the CD2-CD58 complexes are excluded to the dSMAC where they
form the corolla pattern, whereas only around 10% remains trapped around the cSMAC (Figure
5.4). This observation was in accordance with experimental findings [216], and suggested that the
expression level of CD2 can lead to the corolla pattern.
Eventually, I investigated how the strength of the attractive interaction affects the clustering,
starting from very low strength, WAtt, Self = 0.2 and went up to WAtt, Self = 1.0. On the one hand,
in the cases ofRAtt, Self = 0.21−0.28µm, the higher strength resulted in more prominent CD2-CD58
clusters. On the other hand, radii bigger than RAtt, Self > 0.35µm, already managed to clearly
cluster CD2-CD58, and therefore the increased strength did not have any obvious effect (Figure
fig:CD2corollaAttraction), while in some cases, higher attractive strength resulted in reduced CD2-
CD58 amount around the cSMAC (Figure 5.6b, c, d & e).
5.5 CD2 presence in the synapse alters CD28 localization
So far I showed that two very similar in size costimulatory molecules, CD2 and CD28, localized
very differently in the mature synapse (Figures 4.1 & 5.3). But in reality, these two might coexist
in a forming IS. It is experimentally shown that when both CD2 and CD28 were present in the
synapse and interacted with their respective ligands, CD28 complexes relocated in the corolla [216]!
Hence I investigated how the localization of these two costimulatory molecules is affected when
they coexist and what are the possible mechanisms that could lead to the eventual exclusion of
CD28-CD80 toward the corolla.
Initially, both CD2 and CD28, as well as their ligands CD58 and CD80 respectively, where
included in the model. As shown before, CD28-CD80 localize in an annular pattern around the
cSMAC (Figure 5.7a). The introduction of CD2 and the consequent formation of CD2-CD58 com-
plexes that moved to form the corolla pattern did not affect the localization of CD28 significantly.
As seen in Figure 5.7b, there was a minor reduction in the CD28 population around the cSMAC re-
gion. This population then resided together with CD2-CD58 in the corolla. A possible explanation
is that the appearance of low tension regions in and around the corolla could help CD28 passive
followers reside in these regions instead of following the TCR centripetal transport. However, the
experimentally observed transport of the majority CD28-CD80 to the corolla did not appear.



























































Figure 5.3: Appearance of the CD2-CD58 corolla pattern. (Rows) Different radii of attractive
interaction, RAtt, Self , between CD2-CD58 complexes. (Columns) Different initial concentration
of CD2 molecules. (Blue rectangle) First appearance of the CD2-CD58 corolla pattern. (Blue
dashed rectangle) Presence of the CD2-CD28 corolla pattern. TCR-pMHC: green, LFA-1-
ICAM-1: red, CD2-CD58: magenta.











Figure 5.4: Amount of CD2-CD58 during titration of initial CD2 concentration in the three different
regions of the IS, central, peripheral and distal SMACs.
The similar size as well as the similar function of the two costimulatory molecules might suggest
that some type of interaction keeps them together. One such interaction could be an attractive
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TCR-pMHC LFA-1-ICAM-1 CD2-CD58
Figure 5.5: Dynamics of the CD2-CD58 corolla pattern formation (t = 1-30 minutes). TCR-pMHC:
green, LFA-1-ICAM-1: red, CD2-CD58: magenta.
force between CD2 and CD28 complexes. Thus, I introduced an attractive force between the two
kinds of complexes. The interaction radius was defined by RCD2CD28 = 0.14 − 0.35µm) and was
weighted with WCD2CD28 = 1.0. A weak attraction then led to higher exclusion of CD28 toward
the corolla, RCD2CD28 = 0.14µm, whereas an even stronger interaction, RCD2CD28 ≥ 0.21µm, led
to more than 90% of CD28-CD80 in the corolla (Figure 5.7a, b).
In order to visualize the findings of Figure 5.7, I used the colocalization of the two kinds of
complexes. When at least two complexes of both CD2 and CD28 pairs are within a distance of
210 nm, the in silico experiments show that there is colocalization. As can be seen from Figure
5.8, the increasing attraction radius, RCD2CD28, results in higher colocalization in the outer IS
region, where the CD2 corolla pattern is present. This result made clear that indeed an attractive
interaction between the two kinds of complexes, CD2-CD58 and CD28-CD80, can relocate the
second, and that the result is a high colocalization in the dSMAC. The reason for the relocation
of CD28-CD80 could be to support signaling at the periphery, where TCR microclusters form
continuously [108,109,112,201,216,226,227], but this has to be experimentally tested.
Since the experimentally discussed pattern emerged, I then investigated whether the amount
of CD2 on the T cell surface played a role in the emergence of this pattern. The initial amount of
CD2 was titrated between 1 and 54 molecules/µm2, together with the variation of the attraction
range, RCD2CD28. In Figure 5.9a (top and bottom graphs), the mean localization of CD2 is shown
in grey and the deviation from the mean in black. Interestingly, at very small CD2 concentrations,
1 − 4 molecules/µm2, the majority of CD28 resided in the cSMAC region despite the attractive
interaction. Moreover, at these low CD2 concentrations, CD2 was not managing to form the corolla,
but instead was pulled toward the annular CD28 pattern (Figure 5.9b). Irrespective of that, and
since these very low CD2 concentrations are unrealistic, the attraction strength between CD2 and
CD28 and not the CD2 concentration appeared as the driving factor behind CD28’s displacement
in the corolla.
Finally, to further highlight the importance of the LFA-1 gradient, and the strength of the
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Figure 5.6: Alterations in strength, WAtt, Self , and radii, RAtt, Self , of the attractive force, with
initial CD2 concentration CD2 = 36 molecules/µm2. (a Rows) Different radii of attractive inter-
action, RAtt, Self , between CD2-CD58 complexes. (a Columns) Different strengths of attractive
interaction, WAtt, Self , between CD2-CD58 complexes. (b, c, d & e) Radial density profiles of
CD2-CD58 complexes along the distance from the center of each row of (a). TCR-pMHC: green,
LFA-1-ICAM-1: red, CD2-CD58: magenta.
model, I performed in silico simulations for different coupling strengths of LFA-1-ICAM-1 to the
centrally directed flow of F-actin. As was mentioned so far, the emergence of the LFA-1 gradient
acts as an exclusion mechanism both for free molecules (Figure 3.7) as well as for complexes
(Figures 4.1, 5.3). Therefore, as seen in Figure 5.10a, absence of LFA-1 centripetal transport,
CLI = 0.00, does not result in the CD2 corolla but rather in clusters around the cSMAC of CD2
and CD28 complexes. Gradually increasing the strength of the LFA-1 coupling to F-actin resulted
in incomplete exclusion of the CD2 clusters, CLI = 0.03, whereas very strong LFA-1 centripetal
transport led to significant exclusion of CD2 and CD28 complexes. Additionally, the stronger the
coupling of LFA-1 to F-actin, the denser the LFA-1 ring is in the pSMAC (Figure 5.10a). Moreover,
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the strength of CD2-CD28 attraction again resulted in CD28 displacement from the cSMAC region
toward the dSMAC corolla, where around 90% of all CD28-CD80 complexes accumulated (Figure
5.10b).
No CD2 RCD2CD28=0.00m RCD2CD28=0.14m RCD2CD28=0.21m RCD2CD28=0.28m RCD2CD28=0.35m











Figure 5.7: CD28 relocates to the CD2 corolla provided there is a weak attraction between CD2
and CD28 complexes. (a) IS pattern formation, within various attraction radii, RCD2CD28. (b)
Amount of CD28 in the central and distal SMAC for the various attraction ranges, RCD2CD28.
TCR-pMHC: green, LFA-1-ICAM-1: red, CD2-CD58: magenta, CD28-CD80: yellow.
RCD2CD28=0.00m RCD2CD28=0.14m RCD2CD28=0.21m RCD2CD28=0.28m RCD2CD28=0.35m
Figure 5.8: Colocalization of CD2-CD58 and CD28-CD80 complexes for different attraction radii
between them. Colocalization: cyan
5.6 Conclusions
The localization mechanisms of the costimulatory molecule CD2 was subject of investigation in this
chapter. The model showed that the corolla pattern requires the exclusion of CD2 by LFA-1 com-
plexes due to SBS and an additional attractive force between CD2-CD58 complexes. The amount
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% CD2-CD58 & CD28-CD80 in cSMAC during CD2 titration
Figure 5.9: CD2 and CD28 localization during CD2 titration and CD2-CD28 attractive force
range variation, RCD2CD28. (a) Average CD2 population size and CD28 localization for different
attractive force strength, in distal (top) and central (bottom) SMAC. (b) IS pattern formation
for different RCD2CD28 for low (left) and high (right) CD2 concentrations. TCR-pMHC: green,
LFA-1-ICAM-1: red, CD2-CD58: magenta, CD28-CD80: yellow.
of CD2 showed a switch-like behaviour, with low concentrations resulting in central localization,
whereas an increased amount showed that around 90% of the CD2 molecules present in the IS
went to the dSMAC where they formed the corolla pattern.
The experimental observation of CD28-CD80 relocation to the corolla in presence of CD2-CD58
was recapitulated by the introduction of an attractive force between CD2-CD58 and CD28-CD80
complexes. Finally, the importance of the LFA-1 gradient was shown once again. In absence of
the LFA-1 gradient, the corolla pattern was not formed, while the stronger the centripetal LFA-1
force, the higher the exclusion of CD2 from the central IS region.
In the next chapter, the model will be utilized in order to investigate the proposed TCR-
pMHC affinity modulation during pMHC titration and discuss possible mechanisms that result in
this TCR behaviour.
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Figure 5.10: Alterations in strength of LFA-1 coupling to the F-actin flow, CLI. (a) IS pattern
formation for different CLI. (b) Amount of CD28-CD80 complexes in the central and distal SMAC
during LFA-1-F-actin coupling strength variation. TCR-pMHC: green, LFA-1-ICAM-1: red, CD2-
CD58: magenta, CD28-CD80: yellow.
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Chapter 6
T cell receptor cooperativity
6.1 Introduction
TCR binding to the presented pMHC is shown to be a low affinity interaction [140, 228, 229], al-
though T cells are so sensitive to this interaction that even a single pMHC can trigger cytokine
production [230]. Stone et al. also showed that TCRs can discriminate between different pMHC
molecules based on their association rates, kon, during sampling of the APC surface [231]. Fur-
thermore, recent experimental evidence suggested that the observed TCR affinity toward antigen
is actively modulated during the early steps of TCR signaling, i.e. TCR-pMHC microcluster
formation [183,232].
It is observed that the avidity of microclusters is dependent on pMHC density, and that at low
doses, an increase of pMHC density increases the avidity of the interaction. This was interpreted
as cooperativity between TCRs to increase their affinity toward pMHC, during the accumulation
of TCR-pMHC complexes [183]. This behaviour was shown to operate on a narrow time window,
where the initial TCR-pMHC ligations favor further binding events [232]. Pielak et al. detected
that the dwell time, τoff , and consequently the dissociation rate, koff , of individual TCR-pMHC
complexes remains unchanged. This led to the assumption of active modulation of the association
rate, kon. This could be a result of a pMHC seeing multiple TCRs, since the latter have been
observed to be pre-organized in nanoclusters [94, 142, 233–235]. It was also shown that TCR-
pMHC accumulation in the central supramolecular activation cluster (cSMAC) at the later stages
of IS formation results in signal termination [108], suggesting that the earlier antigen recognition
could result in better TCR signaling.
It is unclear how the association rate, kon, is modulated. Is there a feedback on the association
rate, kon? And if this feedback exists, where does it come form? These important questions
remain unanswered. Is it a result of the changes of the cortical actin cytoskeleton [71,109]? Is the
generation and transmission of inside-out signals from the T cell cytoplasm toward the adhesion
molecules (LFA-1) able to stabilize the T cell on the APC surface, which can consequently lead
to easier APC surface scanning by TCRs [236, 237]? Could it be allostery that affects the way
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a ligand binds in presence or absence of other binding events [238, 239], or eventually a feedback
from the F-actin foci [121]?
F-actin foci are dynamically polymerized structures resulting from local nucleation of F-actin,
and appear at TCR-pMHC sites [112,121]. There is evidence that F-actin can bind to phospholipase
C-γ1 (PLCγ1), a key regulator of calcium flux downstream of TCR activation [39, 240]. Interest-
ingly, F-actin foci depletion does not alter the IS pattern, it does manage though to reduce the
degree of PLCγ1 phosphorylation [121], suggesting that F-actin foci may locally upregulate PLCγ1
phosphorylation [241], and consequently alter the observed association rate, kon, of TCR-pMHC
complexes, as suggested by Pielak et al [183].
I show that, without specific active mechanism, the observed avidity between the receptor and
ligands is evolving over time. These changes depend on the density of pMHC and TCR molecules
on the respective cells. Comparison of centrally directed flow of TCR-pMHC pairs due to F-actin
coupling or absence of it suggested centripetal transport as a possible mechanism for the affinity
modulation. The model further suggested that time of affinity measurement is critical, resulting
from the higher affinities obtained at the later time points of synapse formation. This result was
further supported by the experimental observation that the cooperative TCR behaviour peaks
between 4 and 8 minutes after IS formation initiation. Finally, a mathematical model of F-actin
foci formation was incorporated in the agent-based model. In silico experiments showed that TCR
affinity toward pMHC could potentially be actively modulated by a positive/negative feedback on
the association rate kon, when TCRs colocalize with F-actin foci.
6.2 TCR affinity modulation during antigen recognition
Pielak et al [183] observed that the density of pMHC molecules impacts on the observed affinity of
the interaction between microclusters of TCR and pMHC molecules. In order to discriminate which
kind of mechanisms could explain this property, I utilize the agent-based model of immunological
synapse formation [180]. The model takes into account the diffusion of molecules and complexes,
chemical kinetics for binding and unbinding, steric exclusion of different sized complexes, called
size-based segregation (SBS), which is modeled as a repulsive force, and finally, a centrally-directed
flow of the complexes present in the IS, TCR-pMHC and LFA-1-ICAM-1, due to F-actin coupling
[179, 180]. According to experiments, the readout under investigation is the in situ dissociation





This value represents the inverse of the affinity between TCR and pMHC molecules. The dwell
time between TCR-pMHC complexes has been observed to remain constant [183], suggesting that
the dissociation rate, koff , is not changing, but rather that the association rate, kon of TCR
microclusters toward pMHC molecules is modulated over time.
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In order to remain in accordance with the experimental procedure, simulations were performed
using a constant density of TCR molecules, and the pMHC amount was titrated between 0.07
and 100 molecules/µm2. The cellKD observed in the simulations is shown at different pMHC
densities, without altering the association or dissociation rates, kon and koff respectively, of TCR-
pMHC complex formation (Figure 6.1). Interestingly the pMHC titration resulted in a behaviour,
qualitatively similar to the experiments, as seen in Figure 6.1a, while the observed IS patterns
were different for the different pMHC concentration (Figure 6.1b), due to moderate or excessive
pMHC expression. The cellKD was systematically decreasing as the pMHC density was increasing
until a minimum value was reached, after which the cellKD value increased again. The minimum
value reached represents the optimum affinity between TCR and pMHC molecules. According to
experiments, this optimum coincides with the activation threshold for the T cell. By comparison
with the experimental setting, the absolute pMHC number required to reach a minimum of cellKD,
i.e. maximum affinity, is higher in the in silico experiments, probably due to the absence of T cell
activation in the model. These results suggest that the pMHC density plays an important role for
the observed TCR-pMHC affinity.













  TCR-pMHC LFA-1-ICAM-1
Figure 6.1: TCR affinity modulation during IS formation. (a) In situ dissociation constant, cellKD,
for different pMHC densities. Error bars represent the SD of n = 10 simulations. (b) Immunolog-
ical synapse snapshots after 10 minutes of contact initiation, for different pMHC densities. Data
taken from Pielak et al. [183]. TCR-pMHC: green, LFA-1-ICAM-1: red.
6.3 TCR-pMHC affinity is also affected by the TCR density
I then asked whether the TCR density may play a role in regulating cellKD. The model predicted
that by varying the density of TCR in the synapse area from 4.5 to 55.5 molecules/µm2 while
repeating pMHC titration (Figure 6.2a), cellKD qualitatively followed the same behaviour for all
the TCR densities checked. In all cases, cellKD initially decreased, reached a minimum value and
then increased again.
Interestingly, not only the value of pMHC molecules to reach a minimum changed, but also the
minimum was achieved at different points depending on the TCR concentration on the synapse area
(Figure 6.2b). The minimum cellKD was shifting toward higher pMHC densities as the TCR density
increased. This suggests that the density of TCRs present in the synapse plays an important role
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for antigen recognition. The results for very low pMHC concentrations, ≤ 1/µm2, showed very
high cellKD deviation from the mean, making them hard to interpret. This happens because pMHC
are so few that TCRs fail to find them while scanning the APC surface. Therefore, results with


























Figure 6.2: Affinity modulation during TCR amount titration. (a) In situ dissociation constant,
cellKD, changes during TCR amount titration. Error bars represent the SD of n = 10 simulations.
(b) Minimum cellKD values for each TCR density (grey axis) during TCR amount titration and
pMHC density (red axis) for which the minimum cellKD values are achieved.
6.4 A possible mechanism for TCR affinity modulation
Interestingly, the previous results were obtained without active modulation of the association,
kon, or dissociation, koff rates. All the changes resulted only from the pMHC or TCR density
titration. But the question why that happens is still not answered. Is there a mechanism in
the model that allows for this behaviour that was not appreciated so far? In an attempt to
shed light on why cellKD is actively modulated during synapse formation, I decided to check
mechanisms which have a direct impact on synapse formation. One such mechanism suggested
both experimentally and theoretically, is the coupling of molecules to the centripetal flow of the
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F-actin arcs [104,105,116,180]. The strength of the model is that it can be used to perform further
in silico experiments with targeted inhibition of mechanisms. Therefore, the centrally directed
transport of the complexes present in the IS was inhibited. The same experiments are easy to
perform, since there are known F-actin inhibitors [242–244].
Interestingly, arrest of F-actin coupling resulted in a qualitatively different behaviour (Figure
6.3) than before (Figure 6.2). pMHC as well as TCR titration, resulted in constant or in some
cases, TCR≥ 37/µm2, slowly decreasing cellKD. Even in the cases of decreasing cellKD, the mini-
mum was not reached and consequently the value failed to increase again. Therefore, as the model
predicts, further experiments should be performed with F-actin actin depletion [242–244], to in-
vestigate whether the centrally directed motion of TCR-pMHC complexes indeed supports TCR
cooperativity and also assists in the transition from decreasing to increasing cellKD. This behaviour
can be considered as a transition from positive to negative feedback on TCR affinity [183]. All
together, the centripetal transport of complexes due to interactions with the F-actin flow could be




















Figure 6.3: Affinity modulation during TCR and pMHC amount titration, in presence (solid lines)
or absence (dashed lines) of complexes coupling to F-actin.
6.5 Affinity dynamics suggest time of measurement
I then investigated the time evolution of the affinity changes with and without interactions of
complexes with F-actin (Figure 6.4). During the first minute of the in silico experiments, both
centrally directed movement or absence of it, resulted in constant or slowly decreasing cellKD
(Figure 6.4), in contrast to what was observed in Figure 6.2.
At later times points though, 2-10 minutes, as the pMHC density increased, cellKD initially
decreased, reached a minimum value and then increased again, similar to Figure 6.2. As also
shown in Figure 6.3, this behaviour is not observed when actin coupling of molecules is arrested.
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Furthermore, the minimum value of cellKD kept on decreasing as the measurement was performed
at later time points (i.e. 10 minutes) (Figure 6.5). In case of F-actin arrest, cellKD remained
at constant levels throughout the in silico experiments. Together, these results showed that the
time point of the observed affinity measurement is important, allowing for clear indication of
TCR affinity modulation around 5 minutes after the initiation of immune synapse formation. The
model is in accordance with experimental findings, which suggest that the peak of cooperativity is
achieved between 4-8 minutes after the first observed binding event [232].
So far I showed that TCR and pMHC densities are important for the changes in cellKD. There-
fore, I decided to investigate whether the in situ dissociation constant is affected when the total
TCR and pMHC population is kept constant (TCR+pMHC=constant) while titrating the amount
of both, i.e. changing the ratio TCR/pMHC (Figure 6.6). As in every case investigated so far, the
first minute of cellKD measurement showed similar values with or without F-actin coupling for the
complexes present in the IS. This behaviour again changed as the measurement was performed at
later time points, 2-10 minutes. For low TCR and high pMHC, and vice versa, high TCR and low
pMHC densities, cellKD values remained high. But this changed when the amounts of TCR and
pMHC were similar, and the minimum value of cellKD was achieved. Interestingly, the maximum
affinity was found at pMHC densities, similar to Figures 6.2 and 6.3.
6.6 An F-actin foci model
Although the results already suggested that the centrally directed motion of TCR-pMHC pairs is
a possible mechanism for the TCR affinity modulation, I further investigated if active modulation
of the association rate, kon, could produce the same results. According to experimental findings,
the dissociation rate, koff was not affected. A possible mechanism suggested in the literature is
the F-actin foci, which assist in TCR activation and signaling [121]. F-actin foci are dynamically
polymerized structures resulting from local nucleation of F-actin, and appear at TCR-pMHC sites
[112,121].
In this model, TCR-pMHC binding leads to nucleation of F-actin molecules, which are called
nucleation points. In presence of LFA-1-ICAM-1, these nucleation points get polymerized, labelled
nucleation polymerized points (Figure 6.7a). Additionally, presence of LFA-1-ICAM-1 in this
neighborhood, Rneighborhood, leads to polymerization of F-actin molecules around nucleation or
polymerized nucleation points. These polymerization points form clusters, which correspond to
the experimentally observed F-actin foci (Figure 6.7b).
When TCRs colocalize with these clusters, their probability to bind to pMHC is actively modu-
lated by a parameter called Binding coefficient (BC). BC enters the model as a coefficient multiplied
with the probability of a complex to form,
pon = BC × τ × kon
V ×NA ,


















































Figure 6.4: Time evolution of cellKD during TCR and pMHC titration, in presence (solid lines) or
absence (dashed lines) of F-actin centripetal transport, at 1, 2, 5 and 10 minutes respectively.
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Figure 6.5: Time evolution of min(cellKD) during TCR and pMHC titration, in presence (solid
lines) or absence (dashed lines) of F-actin centripetal transport.
where τ is the time step, V is the volume, NA is Avogadro’s number and kon the association rate of
the forming complex. The model allows to investigate both positive and negative feedbacks from
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Figure 6.6: Time evolution of cellKD during TCR and pMHC titration, in presence (solid lines)
or absence (dashed lines) of F-actin centripetal transport. The total amount of TCR and pMHC
molecules remains constant during titration.
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Figure 6.7: F-actin foci modeling. a Model for F-actin foci formation. b Formed F-actin foci
during IS formation. Nucleation points: cyan, nucleation polymerized points: red, polymerization
points: green.
6.7 Modulation of TCR-pMHC association rate by posi-
tive/negative feedback from the F-actin foci
Now that F-actin foci have been implemented into the model I initially had to investigate whether
the observed changes in cellKD remained as before (Figures 6.2 & 6.3). To do this, the control in
silico experiments were performed with BC set to 1, BC = 1. In this case, the measured cellKD
values obtained in Figure 6.8 (top row) were similar to Figure 6.4.
As seen before, at later time points, coupling to actin resulted in decreasing cellKD for low pMHC
densities, which eventually reached a minimum value and then increased again with increasing
pMHC densities. Interestingly, the affinity saturated after 10 minutes of synapse formation, as
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seen at 30 minutes in Figure 6.8 (solid magenta line).
I then investigated how BC can affect this behavior. Initially, I increased from BC = 1 to
BC = 2 and 10. On the one hand, the minimum cellKD value reached kept on decreasing as BC
increased (Figures 6.8 (middle row), 6.9 (middle row)). These results showed that affinity can
increase if there is a positive feedback on the probability of TCR binding. On the other hand,
decreasing the binding coefficient, BC = 0.5 and 0.1, therefore having a negative feedback from the
F-actin foci, did not alter the minimum cellKD value significantly compared to the case of BC = 1
(Figures 6.8 (bottom row), 6.9 (bottom row)). The reason for this behaviour is a direct outcome of
the model (Figure 6.7). Foci formation already requires TCR-pMHC binding. When overlapping
with foci, TCR-pMHC binding is impaired, but everywhere else on the T cell surface the binding is
happening normally, with the association and dissociation rates, kon and koff , shown in Table 2.1.
Therefore, the small overlapping foci and TCR regions are not able to affect the observed affinity
values compared to the case without feedback.
Finally, Figure 6.10 shows how the cellKD valued is affected in presence (positive and negative)
or absence of TCR binding feedback. Starting from the case of absence of feedback (black line),
and as Figures 6.8 and 6.9 suggested, positive feedback (red and blue lines) reduced cellKD and
therefore the affinity was increasing, while negative feedback (green and orange lines) did not alter
the cellKD significantly compared to the case of BC = 1.
All together, these results suggested that TCR-pMHC affinity can be positively modulated
by interaction with the F-actin foci, which in turn can act as positive regulators of the binding
probability. The feedback alone in the absence of centripetal flow of complexes though failed to
reproduce the characteristic trend of decreasing, reaching a minimum and then increasing again
the cellKD value. This suggested that the centripetal transport of the complexes is more important
than even a strong feedback (BC = 10). This analysis could be experimentally confirmed by
inhibition of F-actin arc and F-actin foci formation [121, 242–244], and comparison of obtained
cellKD values.
6.8 Conclusions
In this chapter, the developed agent-based model was not used in order to understand mechanisms
of pattern formation, but to investigate how TCR molecules react to different pMHC concentrations
during the process of antigen recognition. The model suggested that the experimentally observed
cellKD changes can be recapitulated by the centrally directed flow of TCR-pMHC complexes,
without including additional mechanisms. Blockade of the centripetal movement showed only
minor increase in the affinity over time, instead of the switch-like behavior from positive to negative
regulation of the affinity during pMHC titration.
The implemented F-actin foci model acted as an active positive regulator of the association
rate of TCR-pMHC complexes, kon. This positive feedback from the foci, resulted in increased
TCR and pMHC affinity and was observed for all the different pMHC concentrations investigated.




























































































Figure 6.8: Time evolution of the effect of the binding coefficient, BC, on cellKD, with presence or
absence of centripetal transport of complexes.
This mechanism though was not able to act alone, since the centripetal transport was still needed
to obtain the cooperative behaviour.
These two mechanisms, centripetal flow of TCR-pMHC complexes and active modulation of
the association rate by the F-actin foci, can be experimentally investigated, by either blocking the
centripetal F-actin transport with F-actin or myosin II inhibitors, or by inhibiting the F-actin foci


























































































Figure 6.9: min(cellKD) dynamics during feedback from the binding coefficient, BC, in the presence
or absence of centripetal transport of complexes.

















Figure 6.10: cellKD changes during pMHC concentration titration and positive or negative feedback
from the binding coefficient, BC, in presence of centripetal transport of complexes.
Chapter 7
Discussion
7.1 Mechanisms of IS pattern formation in the presence of
a costimulatory molecule
I developed a phenomenological agent-based model for the investigation of the localization mech-
anisms of different molecules present in the cell-cell contact interface. The model focused on the
abstract IS formation, where TCR, pMHC, LFA-1 and ICAM-1 molecules were considered. This
basic model was complemented with molecules important for TCR signaling, such as the phos-
phatase CD45 and the costimulatory molecules CD28 and CD2, with their respective ligands,
CD80 and CD58.
TCR-pMHC centripetal flow together with the SBS between TCR-pMHC and LFA-1-ICAM-1,
led to the formation of microclusters that traveled toward the center, merged into bigger clusters,
and finally formed the cSMAC, confirming previous experiments [68,79], and models [166,171]. The
model predicts that the coupling of LFA-1-ICAM-1 to F-actin induces a gradient of these complexes
within the pSMAC with a higher density toward the cSMAC. The formation of the gradient
relies on the combination of diffusion and actin-coupling. The predicted gradient is confirmed in
experimental settings [104, 116, 196], however, its relevance for other molecules in the IS has not
been appreciated so far. The model showed that freely diffusing molecules are excluded toward
the dSMAC by the forming gradient, as was also experimentally observed [196]. The strength of
the LFA-1 coupling to the actin flow eventually resulted in the separation of the freely diffusing
molecules into two populations, one in the cSMAC region and the other in the dSMAC. In the
case of CD45 molecules, repulsive interactions with TCR-pMHC, combined with the emergence
of the LFA-1 gradient, resulted in the formation of a ring of CD45 molecules in the dSMAC,
recapitulating experimental observations [185,197].
The halo of free space devoid of LFA-1, generated by the SBS between LFA-1 and TCR com-
plexes, allowed TCR to move through the dense pSMAC. Interestingly, complexes with similar
sizes to TCR were also located in these open areas, allowing them to move through the pSMAC
by passively following the TCR centripetal flow (Figure 4.1a). Despite that, the LFA-1 gradient
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acted as an exclusion mechanism for complexes too, pushing them away from the pSMAC, either
toward the central or the distal SMAC (Figures 3.7, 4.5b). This suggests that the LFA-1 gradient
impedes molecules and complexes from escaping or entering the cSMAC. The stronger the coupling
of LFA-1 to actin, the more it affected the localization of other molecules and complexes (Figures
3.7).
The model predicts that a substantial amount of CD28 complexes behave as passive followers
of the TCR-pMHC microcluster movement and localize around the cSMAC (Figure 4.1a). This is
a result of two mechanisms: SBS of LFA-1-ICAM-1 and CD28-CD80 complexes in the pSMAC,
which pushes CD28 complexes into the microclusters, plus actin-driven transport of TCR-pMHC
complexes toward the cSMAC, which opens up low tension paths for CD28 complexes toward
the IS center. The model results show that the previously undescribed mechanism of passive
following is in part responsible for the localization of CD28 in a ring around the cSMAC. Similar
was the behaviour of CD2 complexes, due to the similar size with CD28 complexes. The higher
concentration of CD2 though resulted in a more pronounced exclusion toward the dSMAC.
Coupling of CD28 to actin was sufficient to guide CD28-CD80 complexes together with the
TCR-pMHC microclusters to the cSMAC (Figures 4.1, 4.2) [196]. The ring-like positioning of
CD28 around TCRs was best achieved with an optimal strength of the centripetal flow of CD28-
CD80. In the limit of strong coupling of CD28 to actin, the intermixed pattern in the cSMAC
(Figures 4.8a) could not be resolved by SBS between CD28-CD80 and TCR-pMHC complexes and
restore the ring structure (Figures 4.10b, c). SBS was even unable to affect the ring structure in
the IS with optimal CD28 coupling to actin (Figure 4.10a). Thus, the model predicts that the
optimal CD28-CD80 coupling to actin is weaker than for TCR-pMHC. The actin force acts as the
regulator of CD28 distal to central SMAC ratio (Figure 4.8).
In the in silico experiments, TCR-pMHC led the way toward the center of the IS, while CD28-
CD80 followed (Figures 4.1a (a-d), 4.2b). This suggests an early separation of TCR and CD28
during IS formation. The CD28 ring forms because TCRs reach the center faster. The spatial
resolution of the model between 17 and 100 nm allowed for a more detailed insight of surface
molecule movement than currently available experimental data, based e.g. on TIRF (total internal
reflection fluorescence) microscopy (' 100 nm resolution). Therefore, experiments with higher
resolution imaging would be needed to confirm the early segregation of CD28 and TCR, such as
STORM (stochastic optical reconstruction microscopy) imaging (' 20 nm resolution) [93].
By showing that actin has a critical role in the relative positioning of molecules inside the
IS, especially signaling molecules such as TCR, LFA-1 and CD28, this work further suggests that
actin is important for bringing signaling molecules together and structuring signaling pathways
in time and space. It has been suggested that TCR signaling is more potent in the microclusters
compared to the cSMAC, likely related to the exhaustion of TCR signaling complexes [112,226,227].
The model reveals that actin coupling increases the amount of CD28-CD80 complexes in the
vicinity of TCR-pMHC microclusters (Figure 4.2) and strengthens costimulation in microclusters,
as also suggested experimentally [196,209,210,245]. In contrast, in the outer cSMAC, there is high
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colocalization of CD28-CD80 and TCR-pMHC when the CD28 ring forms, but a low colocalization
in the inner cSMAC. Together with the presence of phosphorylated PKCθ around the cSMAC [196],
this suggests that there is still signaling in that area, but the degree of colocalization deep in the
cSMAC decreases and reduces signaling [72,108].
The analysis and implications of transmembrane molecules coupling to actin was in the focus of
the developed model. Actin coupling was modeled as a phenomenological centripetal force acting
on molecules. While this representation is justified for the analysis of IS pattern formation, the
mechanisms behind the actin re-orientation and transport toward the center of the IS were not
considered [105]. A more explicit representation of the actin dynamics would allow going deeper
into the coupling mechanisms and investigate complex interactions governing the binding to actin
such as the suggested frictional coupling [100]. This work shows that the strength of coupling to
centripetal forces is critical for the organization of the IS, and opens the question whether coupling
to actin is a regulated process or could be manipulated by chemical compounds. It could be
interesting to assess in silico whether this process impacts on the speed or coupling of molecules
to the actin flow.
This work led to the creation of a very powerful agent-based model [180], which I used as a
tool to investigate additional characteristics of the forming IS, including not only the localization
of other molecules, but also properties such as TCR cooperativity.
7.2 The interesting case of CD2 molecules
The case of CD2 complexes is also interesting, since their comparable sizes to TCR-pMHC and
CD28-CD80 complexes would suggest a similar ring-like pattern with CD28 or even an intermixed
cSMAC with TCR. Nonetheless, CD2 complexes are not only excluded to the dSMAC region, but
also form clusters in a flower petal-like structure known as corolla pattern. Similar to the CD28
case, CD2 molecules behaved as passive followers of the centrally-directed flow of TCR, due to
mutual repulsion with LFA-1-ICAM-1 as a result of SBS. The majority of CD2 complexes was
excluded to the outer region of the contact interface but required self attraction, i.e. CD2-CD2
attraction, for clustering (Figure 5.3). The model showed that the amount of CD2 played an
important role in its localization. The in silico CD2 titration led to a step-like behaviour, where
at low CD2 concentrations, passive following of TCR-pMHC transported the majority of CD2 to
the cSMAC region, whereas at higher concentrations, around 90% of the CD2 complexes were
excluded to the dSMAC where the corolla pattern appeared (Figure 5.4), also complying with
experimental observations showing that the CD2 amount controls the corolla formation [216]. In
this case, interaction of CD2 with actin was not needed. One could argue that the attractive forces
required by the model to cluster CD2 complexes can be a result of CD2-actin interactions. The
proof of such a mechanism would require additional experiments.
The exclusion of CD2 might also have evolved in order to enhance TCR signaling. CD2-CD58
complexes are shown to synergize with TCR, resulting in enhanced PLCγ1 phosphorylation [223].
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The exclusion of CD2 could act in a way to increase TCR calcium flux in the peripheral region of the
IS, further supporting the idea of signaling in microclusters instead of the cSMAC [112,226,227].
Looking at the completely different locations of two similar - at least size-wise - complexes, it
is clear that T cell signaling gets even more complicated. Apart from the very complex signaling
cascades presented in Figure 1.10, the different costimulatory molecule localizations seem to be
important too. The questions that remain to be answered are where exactly does signaling take
place during IS formation and how the costimulatory molecules affect it.
Interestingly though, when both CD28 and CD2 find their ligands, the localization of CD28
changes from the ring-like structure around the cSMAC to colocalization with CD2 in the corolla
[216]. The model was able to recapitulate this strange behaviour, by a phenomenological, attractive
force between CD2 and CD28 complexes (Figure 5.7). In the absence of such a force, the localization
of the two kinds of complexes was not affected. The translocation of CD28 to the corolla might also
be a way to enhance signaling during the early stages of antigen recognition and TCR activation.
7.3 TCR cooperativity and active affinity modulation
In this study I additionally developed an actin nucleation model, simulating the dynamics of F-
actin foci formation and feedback on the association rate of TCR molecules. This model was
implemented in the already developed agent-based model of IS formation dynamics [180]. The
new model was used to investigate the mechanisms behind the suggested active modulation of the
association rate of the T cell receptor during antigen discrimination [183,232].
The in situ dissociation rate, cellKD, was calculated as the fraction of the density of unbound




model showed that during IS formation, pMHC titration leads to a qualitatively similar behaviour
to experiments [183], but required a 10-fold higher pMHC density to achieve the maximum affinity
(Figures 6.1 &,6.2). Experimentally, the maximum affinity coincided with NFAT translocation, and
therefore T cell activation [183]. Afterwards, cooperativity becomes negative (cellKD is increasing),
with a possible explanation being the exhaustion of bigger TCR-pMHC clusters in which signaling
is terminated as they reach the cSMAC [108]. Earlier studies showed that during T cell activation,
conformational changes and avidity increase of TCR towards pMHC are leading to improved sensing
of low antigen amounts [140, 141, 246, 247]. TCR cross-linking though can be excluded form the
possible mechanisms [141,248–250], at least for the lower pMHC densities, since no physical contact,
between TCR-pMHC complexes was observed during the phase of positive cooperativity. Instead,
during the formation of bigger clusters the TCR behaviour changed to being anti-cooperative [183].
Additionally, the finding that even a single pMHC triggers multiple TCRs and cytokine production
[230], suggested that there is a missing mechanism in the model, which might be essential for
reducing the densities to the levels predicted experimentally. Nonetheless, the qualitative behaviour
is similar between in silico and experimental observations.
The model qualitatively reproduced the results without active modulation of the association
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rate of TCR and pMHC molecules, kon. Therefore, I looked deeper into the in silico experiments
trying to understand how the cooperative behaviour emerges. A first step was to inhibit IS for-
mation and measure affinities. The motivation came from the finding that a certain small amount
of TCR-pMHC binding events was needed in order to initiate their retrograde flow and eventually
their accumulation in the cSMAC [183]. These simple simulations were performed by inhibiting
the centripetal movement of the complexes and causing therefore the accumulation of TCR-pMHC
in the cSMAC. Surprisingly, these straightforward simulations showed major differences in cooper-
ativity, with titration of pMHC not effectively altering the observed cellKD, and the two stages of
positive and negative cooperativity not being observed (Figure 6.3). Together, these results sug-
gested that cooperativity can simply be a side effect of IS formation. As the initial TCR-pMHC
binding events happen, they start forming clusters and move towards the center of the contact
region. In this way, free TCRs trapped inside these clusters can find more pMHC on the way,
or free pMHC trapped in these clusters can sequentially bind to multiple TCRs resulting in the
observed increase in affinity [94, 234, 235]. These experiments can be performed by inhibition of
F-actin arc formation [104,105].
The model also showed that the time of affinity measurement is crucial. The affinity modulation
could be clearly observed around 5 minutes after initiation of IS formation, in accordance with
experimental findings [232].
The active modulation of the association rate, kon, of TCR towards pMHC was the subject of
further investigations, since the dissociation rate, koff , was observed to remain unchanged [183].
If this was true, would allostery affect the affinity by modulating only kon [232, 238]? In order
to investigate if and how active modulation of kon affects the affinity, an F-actin foci model was
implemented (Figure 6.7). This allowed the model to actively modulate the association probability
based on a parameter dependent on the colocalization of foci and free TCRs, namely the binding
coefficient (BC ). This parameter altered the binding probability and acted as a positive (BC > 1)
or negative (BC < 1) feedback.
On the one hand, the extra positive feedback resulted in more pronounced affinity changes,
by achieving lower cellKD values, suggesting higher cooperativity between TCRs. On the other
hand, the negative feedback did not show significant changes of TCR-pMHC affinities (Figure
6.10). Interestingly, the characteristic IS pattern is still appearing by inhibition of F-actin foci
formation [121], but not by inhibition of the formation of F-actin arcs [104, 105]. The model
showed the centripetal transport of complexes is more important than the active modulation by
the foci, since arrest of centripetal movement even with strong positive feedback from the foci
did not reproduce the two phases of TCR cooperativity (Figure 6.8), from increasing to decreasing
affinity. Even in the case of positive feedback, the maximum affinity obtained by the model required
higher pMHC densities than observed in experiments [183]. The reason behind it might be the
ability of a single pMHC to activate multiple TCRs, which are residing in nanoclusters even before
the initiation of antigen recognition [94, 142, 233–235], which is a mechanism not implemented in
the model, but would require extensive changes in the current implementation.
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7.4 General remarks and model limitations
It has to be noted that the physiological interaction between two immune cells harbors more
complex mechanisms not studied here. The interacting cells build a complex 3D interface with
undulating membranes [84–88]. The cytoskeleton of the APC dynamically changes during IS
formation [95], and different APCs can generate IS patterns with different properties [96]. Actin
protrusions in the form of microvilli push parts of the membrane toward the opposite cell, which
increases the interaction surface [251,252]. Endo- and exocytosis, or recruitment of molecules from
the rest of the cell surface to the IS [150] further increase the complexity of trafficking dynamics.
The presented work was designed to reproduce experimental systems relying on SLBs, where
molecules on the “virtual APC” side move freely (Figure 2.1). In this simplified system, actin
forces on the T cell side can be studied separately under controlled conditions. High resolution
data of the IS were mostly performed on SLBs and those imaging data were used to validate
the model. For instance, the observed size of microclusters [195, 226], the speed of microcluster
movement [100], and the speed of cSMAC formation [79], are consistent with the dynamics of the
model. Despite the lack of more complex mechanisms, the simplified in silico IS model contains the
critical ingredients to recapitulate IS formation and to be in close agreement with experimental
observations on SLBs [71, 79]. But as the results of the model were derived from SLB data, it
remains to be proven that the identified mechanisms apply to real life 3D IS patterns, which
harbor many more complexes with different sizes, such as CTLA-4-CD80/86 and PD-1-PD-L1.
Further, it has been suggested that F-actin transport occurs within membrane extensions [253],
which would correspond to a space-dependent actin coupling in the model [114,254].
Data from 3D T cell-APC interfaces will allow to optimize the model.Finally, despite the
absence of an explicit signaling model, the in silico experiments already pointed to some possible
mechanisms for the observed affinity modulation during antigen recognition. Such a model should
be implemented as a next step toward the direction of investigating TCR signaling in the forming
synapse.
7.5 Future work and model extensions
The model has been able to reproduce many different experimental observations based on very
simple mechanisms. Its ability to do so while studying a very complex system makes it a powerful
tool, which could be used in different ways to improve and assist biological results and also predict
mechanisms that are not foreseen, hard to interpret or even impossible to investigate by the
biological community. Nonetheless, the model remains phenomenological. In order to understand
the effect of membrane bending and undulations, the model could be reformulated in 3D. In
this way, additional data from experiments using cell-cell conjugates would help to parametrize
the model. Consequently, the model could help experimentalists by suggesting and discussing
mechanisms that lead to IS patterns.
A quicker step forward would be to introduce other important molecules to the model. CTLA-4
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is competing with CD28 for the same ligands, i.e. CD80 and CD86, which in turn reduces TCR
signaling [206, 255, 256]. CTLA-4 molecules are localized in an intracellular pool in T cells and
their recruitment to the IS region depends on the strength of TCR signaling [257] and the ligation
to one of its ligands [204]. For this part, modeling of internalization and recycling of molecules
can be introduced, since CTLA-4 trafficking is an important checkpoint regulating autoimmunity
and responses to tumours [258, 259]. Additionally, the model will be implemented with trans-
endocytosis, a mechanism by which CTLA-4 binds to CD80 and/or CD86 on the APC surface and
gets internalized with it [259,260].
Another important checkpoint in tumour immunology as well as autoimmunity is a molecule
known as programmed cell death protein 1, or simply PD-1. PD-1 is not only structurally similar
to CTLA-4, but also can inhibit the function of CD28 and consequently T cell activation [261], just
like CTLA-4. PD-1 has also two ligands presented on APCs, namely PD-L1 and PD-L2 [262,263].
Blockade of PD-1 interaction with its ligands is shown to inhibit immune resistance [264] and
this technique is used for treatment of Hodgkin’s lymphoma [265], melanoma [266, 267] and lung
cancer [268, 269]. It would be interesting to model the localization mechanisms of PD-1 in the
IS [216], as well as possible interactions with the molecules already present in the model, such as
CD28 and CD2.
As explained in Chapter 2, the F-actin flow was modeled as a centrally directed force. A
more analytical representation of the F-actin network would allow understanding F-actin bundle
formation in the dSMAC region, their re-orientation into concentric arcs by interacting with myosin
IIa molecules in the pSMAC, and of course their depolymerization in the cSMAC. Such a model
would help us understand how molecules are transported by coupling to F-actin arcs, an interaction
where experimentalists don’t have answers, at least until now.
Of course, I should not overlook the purpose of IS formation, which is T cell activation driven
by TCR signaling. A signaling model should be introduced into the presented model, such as
the one described by Schmeitz and colleagues [270]. In this case, calcium channels could be
spatially localized on the forming synapse and we could study how TCR signaling is affected by
presence of costimulatory molecules, such as CD28 and CD2 or exclusion of CD45 from TCR-pMHC
sites [134,271–274].
7.6 Conclusions
This work brings new insights into the mechanistic foundations of a mature IS. Understanding
the mechanisms leading to the different characteristic patterns can help biologists understand why
the reorganization of all surface molecules takes place, and more importantly how T cells get
activated because of these emerging patterns. It is known that the formation of stable ISs is an
important step of the body’s defence against pathogens. In autoimmune diseases though, such
as type-1 diabetes and multiple sclerosis [160], as well as in breast cancer [161–164], the synapses
observed are not stable and the T cells fail to get activated and eradicate the danger. Therefore,
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the development of new drugs against the aforementioned diseases can be possibly assisted by a
proper mechanistic understanding of synapse formation. Adding to this equation the vast amount
of signaling molecules present on the T cell-APC interface, we can eventually help in preventing and
eliminating such diseases. The predictions made by the model suggested easy to test experiments
that would help further understand the suggested mechanisms. Hopefully, this work and potential
extensions of it will contribute to the significant increase of our understanding of Immunological
Synapse formation.
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